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Nuclear pore complexes (NPCs) are giant molecular machines embedded in the double 
membrane that surrounds the eukaryotic nucleus. Deciphering the molecular structure of the 
NPCs is critical to our understanding of both cellular architecture and the mechanism of nucleo-
cytoplasmic transport. In less than a decade, atomic level structures of many nucleoporins 
(Nups) have been solved and the molecular picture of the NPC is becoming increasingly clearer. 
Nup62·58·54 subcomplex is a nucleoporin subcomplex in the NPC’s central channel, the 
molecular structure of which, is not known so far. At a sequence level, the N-terminal half of all 
subunits in the complex contain intrinsically disordered phenylalanine-glycine (FG) repeat- 
motifs.  The C-terminal half is structured into coiled-coil domains that engage in tight protein-
protein interactions to hold the complex together and to anchor it to the NPC scaffold. In this 
project, I aimed to elucidate the molecular structure of the X.laevis ∆FG-Nup62·58·54 complex 
by X-ray crystallography. Poor solubility of some coiled-coil domain containing Nups, such as 
Nup54, in bacterial expression has been a challenge towards obtaining large amounts of 
nucleoporins required for crystallographic analysis. We established a system where all three 
subunits of xl∆FGNup62·58·54 were co-expressed together in E.coli. The soluble amount of 
Nup54 was greatly enhanced, when co-expressed together with its interaction partners. 
Biochemical analysis of the recombinant ∆FG-Nup62·58·54 complex revealed a monomeric, non-
spherical complex with a clear 1:1:1 subunit stoichiometry, which had been unclear so far. Also, 
in contrast to previously published reports, the ∆FG-Nup62·58·54 complex did not show any 
tendency to form protein-concentration dependent higher-order oligomers. However, extensive 
crystallization trials failed to crystallize ∆FG-Nup62·58·54 complex, probably due to inherent 
flexibility in its structure. Therefore, we generated and screened a series of single-domain 
antibodies (nanobodies, Nbs) against ∆FG-Nup62·58·54 complex and identified a few that 
stabilized the trimeric complex but did not recognize any of the individual subunits or dimeric 
interactions. Crystallization trials of ∆FG-xlNup62·58·54 complex conjugated to one such 
nanobody, Nb15, yielded rod-shaped crystals, which are currently limited in their diffraction 
potential to ∼7.5Å.  Thus, nanobody conjugation of the ∆FG-xlNup62·58·54 complex aided in its 
crystallization and can be used as a general approach to stabilize NPC subcomplexes. 
Furthermore, a coiled-coil interaction between xlNup93 N-terminus and xlNup62·58·54 complex 
is thought to recruit the Nup62·58·54 complex to the NPCs. This interaction in our experiments, 
however, turned out to be surprisingly weak. This now predicts additional interaction sites for a 
high avidity anchorage of the Nup62·58·54 complex to the NPC scaffold. 
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In a parallel project, we aimed to obtain insights into exportin CRM1’s conformational states by 
analyzing its sequence conservation in a large number of diverse species, starting from lower 
eukaryotes such as Trichomonas till humans. Individual point mutations in 21 absolutely 
conserved CRM1 residues produced interesting phenotypes with either greatly enhanced or 
weakened cargo binding, suggesting that many of these evolutionary conserved residues are 
critical for stabilizing distinct conformational states of cargo-free or cargo-bound CRM1. These 
mutants will be exploited further in structural studies that explore the conformation space 



































2.1. Nucleus: A eukaryotic hallmark  
Evolution of eukaryotic life from single-celled prokaryotic ancestors involved the development of 
a complex endomembrane system leading to compartmentalization of cellular processes. The 
defining feature of eukaryotes (eu meaning “true” and karyo meaning “kernel” or “seed”) is the 
presence of nucleus, which is absent in all prokaryotes. The nucleus is enclosed by a double 
membrane structure called the outer and the inner nuclear membrane (ONM and INM 
respectively) with ONM being continuous with the Endoplasmic reticulum (ER). 
The containment of genetic information in the nucleus gave eukaryotes several advantages over 
their prokaryotic ancestors for a complete regulation of cellular functions that paved way for 
their differentiation into multicellular organisms. First among these advantages was the 
protection of DNA from mechanical shearing or highly reactive free oxygen radicals in the 
cytoplasm, thus imparting enhanced genetic stability. Second advantage was the increase in 
metabolic efficiency caused by increased local concentration of DNA replication, repair, 
transcription and RNA processing machinery inside the nucleus, and its separation from protein 
and fatty acid synthesis in the cytosol. This separation of translational and transcription 
machinery also added a layer of functional regulation by controlling the spatial and temporal 
access of specific activity factors in the nucleus and cytosol. Third advantage was the advent of 
introns and alternative splicing thereby compounding eukaryotic genomic diversity as various 
protein isoforms could arise from a single mRNA transcript. Exclusion of ribosomes from nucleus 
secured that unspliced mRNAs are not prematurely translated since only mature mRNAs are 
exported out of the nucleus (Cavalier-Smith, 1988; Görlich and Kutay, 1999). 
 
2.2. The Nuclear pore complex (NPC) 
The presence of nuclear pore complexes in the nuclear envelope allows exchange of 
macromolecules such as RNA and proteins between nuclear and cytoplasmic compartments 
(Feldherr, 1962). NPCs provide aqueous channels through the nuclear envelope (CALLAN et al., 
1949) (BAHR and BEERMANN, 1954), formed at the sites of fusion between the outer and inner 
nuclear membranes (Watson, 1954) (Figure 1.1a). 
Early electron microscopic (EM) observations of the nuclear membrane in amphibian oocytes 
revealed NPCs to be a cylindrical structure with octahedral symmetry (GALL, 1954; Gall, 1967) 
(Figure 1.1b). Metazoan NPCs have an estimated MW of ∼125MDa (Reichelt et al., 1990), 
whereas the yeast counterpart is relatively smaller with a MW of ∼66MDa (Rout and Blobel, 
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1993). The average inner diameter of NPC is ∼50 nm and the outer diameter ranges from 85-125 
nm (Beck et al., 2004). Despite the differences in molecular dimensions of these giant 
assemblies, EM reconstructions of NPCs across evolutionary divergent species have established 
that the overall architecture is conserved (Grossman et al., 2012). The number and density of the 
NPCs in the nuclear envelope varies in different organisms depending on the nuclear volume 
with a modest ∼200 in yeast (Rout and Blobel, 1993), to an intermediate ∼2000-5000 in human 
cells and a high ∼5 x 107 NPC number in mature Xenopus oocytes (Cordes et al., 1995). 
Chemically, NPCs are entirely proteinaceous assemblies and compared to their large size, are 
comprised of relatively small number of distinct subunits i.e. ∼30 (called nucleoporins or Nups), 
which are present, however, in multiple copies of eight (Rout et al., 2000; Cronshaw et al., 2002). 
The nucleoporins studied across species including mammals, amphibians and lower eukaryotes 
are structurally homologous thus accounting for strong evolutionary conservation of overall NPC 
architecture and function (Yang et al., 1998). 
 
 
Figure 1.1: The Nuclear pore complex (NPC) 
a. Early EM images showing NPCs at the junction of INM and ONM fusion (Watson, 1959). b. Surface view 
of amphibian nuclear membrane in EM showing octahedral NPCs (Gall, 1954). 
 
2.3. Mechanism of nucleo-cytoplasmic exchange 
NPCs are not mere aqueous channels in the NE but in fact, are the ‘only’ portals of exchange 
between the nucleus and the cytoplasm.  The regulated macromolecular exchange at the NPC 
depends upon phenylalanine-glycine motif (FG-motif or repeat) containing nucleoporins that line 
the central NPC channel and form the ‘permeability barrier’ against free diffusion of 
macromolecules. Translocation across the NPC is a rapid, regulated process involving flow of 
nearly 100MDa mass per NPC per second that corresponds to ∼1000 translocation events·NPC -
1·s-1 (Ribbeck and Görlich, 2001). Small molecules with MW ≤30 kDa (or diameter ≤5 nm) can 
pass NPCs by simple diffusion; however, as the size of the molecule increases translocation 
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across the NPC is restricted (Mohr et al., 2009). For crossing this diffusion barrier formed by NPC, 
macromolecules rely on binding to and subsequent facilitated translocation by dedicated 
shuttling factors called nuclear transport receptors (NTRs) (Görlich et al., 1994). The detailed 
mechanism and nature of macromolecular translocation through NPC is reviewed in (Görlich and 
Kutay, 1999) (Hetzer and Wente, 2009) and is briefly described below. 
2.3.1. NPC’s permeability barrier 
The central transport channel of the NPC is filled with FG-repeats of FG-Nups that are crucial 
components for the formation of NPC’s permeability barrier. The FG-repeat domains are 
intrinsically disordered regions (Denning et al., 2003) and contain repeat motifs of GLFG, FxFG or 
FG (where F is phenylalanine, G is glycine, L is leucine, x is any other residue) residues separated 
by hydrophilic spacers. About one-third of the total Nups in a NPC have FG-domains that provide 
binding sites for nuclear transport receptors (Iovine et al., 1995).  
Due to intrinsic disorder in the FG-repeats, direct structural information about the arrangement 
of these motifs in the NPC central channel is not available. Based on the nature of interaction 
between the FG-repeats and the translocation mechanism, several models have been proposed 
to explain the molecular arrangement of FG-repeats in the central transport channel. 
2.3.2. The RanGTP gradient 
A concentration gradient of RanGTP across the nuclear envelope provides metabolic energy for 
driving active NPC transport (Görlich et al., 1996) (Izaurralde et al., 1997). In the nucleus, Ran 
exists predominantly in a GTP bound form whereas in the cytoplasm it is exclusively present as 
RanGDP. The proteins playing key role in maintaining this Ran gradient across the two 
compartments include Ran (Melchior et al., 1993; Moore and Blobel, 1993), Ran shuttling factor 
NTF2 (Moore and Blobel, 1994), Ran nucleotide exchange factor RCC1 (Bischoff and Ponstingl, 
1991), RanGTP hydrolyzing protein RanGAP (Bischoff et al., 1994) and Ran binding proteins 
RanBP1 (Bischoff et al., 1995) and RanBP2 (Wu et al., 1995). 
In the nucleus, nucleotide exchange on Ran from GDP to GTP is catalyzed by guanine nucleotide 
exchange factor RCC1. RCC1 is present exclusively in the nucleus due to its association with the 
chromatin (Ohtsubo et al., 1989). As a result, Ran is maintained in a GTP bound form inside the 
nucleus. On the other hand, RanGTPase-activating protein, RanGAP has an exclusive cytoplasmic 
localization. It acts in association with Ran binding proteins (RanBP1 or RanBP2) to hydrolyze 
RanGTP to RanGDP thereby forcing Ran to be present in a GDP bound form in the cytosol. NTF2 
binds RanGDP in the cytoplasm and brings it to the nucleus (Ribbeck et al., 1998), thus 
maintaining a steady state level of Ran in the nucleus. The concentration gradient of RanGTP or 
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RanGDP across the NE, thus formed, is used to provide directionality to the NPC transport 
(Figure 1.2). NTRs take advantage of this gradient as discussed below.  
 
Figure 1.2: Overview of the nuclear import-export cycles and the RanGTPase system 
Adapted from (Görlich and Kutay, 1999). See text for details. 
 
2.3.3. Nuclear transport receptors (NTRs) 
Nuclear transport receptors (NTRs) are crucial for facilitated transport of all macromolecules 
≥40kDa in size such as majority of transcription factors, histones, RNPs etc. across the nuclear 
envelope. Reviewed in (Görlich and Kutay, 1999) (Güttler and Görlich, 2011).  
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The best-characterized NTRs belong to the Importin-β superfamily that contains large, 
superhelical, α-solenoidal receptors, named after the first receptor identified (Görlich et al., 
1995) (Fornerod et al., 1997a). Structurally NTRS are characterized by stacked arrangement of 
multiple HEAT repeat elements, where a single HEAT repeat element is made up by two α-
helices, 10-20 residues in length, in antiparallel orientation connected by a short linker. NTRs 
bind cargoes in the either cellular compartment through signal recognition mechanisms (Moore 
and Blobel, 1992) (Görlich et al., 1994) and have multiple hydrophobic binding pockets for 
docking to FG-repeats in the NPC (Iovine et al., 1995) (Radu et al., 1995). Cargo release at either 
side of the NPC is facilitated by RanGTP binding or hydrolysis (Rexach and Blobel, 1995) (Görlich 
et al., 1996) and NTRs recycle back to their original compartment for next round of cargo 
binding, NPC translocation and cargo release (Figure 1.2). 
Based on the direction of cargo transport, NTRs can be subdivided into importins or exportins 
(some NTRs work in both directions). Some examples of importins include impβ (imports wide 
range of proteins including ribosomal proteins, HIV Rev, “classical” NLSs with impα as adaptor) 
(Görlich et al., 1995) (Chi et al., 1995), transportin (imports hnRNPs) whereas CRM1 (exports 
wide variety of Leucine-rich NES containing cargoes) (Fornerod et al., 1997a), Exportin-6 (exports 
actin) (Stuven et al., 2003), CAS (exports Impα) (Kutay et al., 1997), Exportin-t (exports mature 
tRNAs) (Arts et al., 1998) etc. are well known exportins. Importins bind their cargoes in the 
cytoplasm at low RanGTP levels and translocate across NPCs as importin-cargo complexes. At the 
nuclear side of NPC, competitive binding by RanGTP displaces cargo and importins return back to 
the cytoplasm across the NPC as importin-RanGTP complexes. At the cytoplasmic side, GTP in 
the importin-RanGTP complex is hydrolyzed, thereby dissociating the complex making importin 
freely available for the next round of cargo transport (Rexach and Blobel, 1995). The converse is 
true for exportins, which recognize nuclear export signals (NESs) to bind their cargoes in the 
nucleus in the presence of RanGTP, forming a ternary export complex that translocates across 
the NPC. RanGTP hydrolysis in the cytoplasm dissociates the export complex and exportins are 
recycled back into the nucleus (Kutay et al., 1997; Fornerod et al., 1997a). 
 
2.4. NPC architecture 
Modularity in the NPC architecture allows us to classify its components in at least three different 
possible ways. Accordingly, NPC structure can be subdivided based on a) structural modules 
visible in the EM images, b) functions of different nucleoporins in the NPC structure and c) 
biochemically stable nucleoporin subcomplexes that occur as soluble entities during NPC’s 
mitotic disassembly and indicate stable nucleoporin interactions in the NPC.  
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2.4.1. Structural organization of the NPC as observed in EM 
A large amount our current understanding of the NPC architecture in different organisms has 
been gathered from electro microscopic (EM) observations (Akey and Radermacher, 1993) 
(Goldberg and Allen, 1993). Using cryo-electron tomography (cryo-ET) techniques, high-
resolution NPC structures from the nuclei of different organisms including Saccharomyces, 
Dictyostelium, Xenopus have been obtained (Beck et al., 2004) (Frenkiel-Krispin et al., 2010). 
Recently, a 6.6nm resolution structure of the human NPC was determined by cryo-ET in intact 
human fibroblast cells, without applying any purification steps, to maintain ‘close-to-life’ state of 
the NPC (Maimon et al., 2012) where critical details of sponge-like NPC structure have emerged.  
Traditionally, based on its visual inspection in the EM, NPC has been divided into a ‘core NPC 
scaffold’ and ‘peripheral components’ attached at either sides of the scaffold, called as the 
cytoplasmic filaments and the nuclear basket (Figure 1.3).  
The NPC core is found to be a tripartite ring-structure consisting of three parallel ring-like 
structures viz. cytoplasmic ring, spoke ring and the nuclear ring along the plane of the nuclear 
envelope (Akey and Radermacher, 1993) (Goldberg and Allen, 1993). Along the axis 
perpendicular to the nuclear envelope, the NPC can be subdivided into eight radial arms or 
spokes that impart it with octagonal symmetry (Goldberg and Allen, 1995). Eight cytoplasmic 
filaments radiate from the cytoplasmic ring into the cytoplasm. Filaments extending from the 
nuclear ring into the nucleoplasm join to form a ring at the distal end called the nuclear basket 
(Beck et al., 2004). The translocation channel at the center of NPC is filled with a meshwork of 
FG-domains of nucleoporins and hence, does not show any distinct structural features (Beck et 
al., 2004). The EM technique is powerful for studying overall structure of the NPC but the current 
limitation in molecular resolution at 6nm does not allow resolution of nucleoporin locations, 
subcomplex boundaries or their relative orientation with respect to each other. 
2.4.2. Classification of Nups based on their function in the NPC 
Based on their structure, amino-acid sequence motifs and NPC location, nucleoporins can be 
classified as following (also see Table 1). 
2.4.2.1. Transmembrane (TM) nucleoporins 
Transmembrane Nups have large membrane-spanning domains that anchor the NPC to the 
nuclear envelope.  In vertebrates, three nucleoporins namely, Ndc1, gp210 (Pom152 in yeast) 
and Pom121 (unique to vertebrates) with trans membrane α-helices have been identified 
whereas in yeast, scPom34, scNdc1 and scPom152 contain TM helices. The molecular structures 
of these Nups are not available and also the details about their interactions with other Nups in 
the NPC are not clearly understood. However, several studies have reported essential roles 
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played by TM Nups during initial phases of NPC assembly and disassembly (Stavru et al., 2006b) 
(Stavru et al., 2006a).  
 
 
Figure 1.3: Structural organization of the NPC 
Cryo-ET reconstructions of a) Dictyostelium discoideum NPC at 9nm resolution (Beck et al, 2004). b) 
Human NPC at 6nm resolution (Maimon et al, 2012). The canonical features of the NPC can be observed in 
the upper structure whereas details of tripartite ring-like NPC structures are easily visible in the bottom 
structure. CR- Cytoplasmic ring, SR- Spoke ring, NR- Nuclear ring. See text for details. 
 
2. Introduction   
 
 20 
2.4.2.2. Scaffold nucleoporins 
About one-half of the total nucleoporins do not contribute directly to the permeability barrier 
and take part in forming the NPC’s structural scaffold. These Nups are termed as scaffold Nups. 
These architectural Nups are symmetrically localized around the two-fold symmetry axis in the 
plane of the NE and in an eight-fold rotational symmetry along the central transport channel in  
the NPC. They form the essential skeleton of the NPC by stabilizing the curvature of the pore 
membrane and have been reported to have extremely long residence times in the NPC spanning 
the entire cell cycle (Rabut et al., 2004). Alpha-solenoids and beta-propeller domains were 
predicted to be the main structural components for the scaffold Nups (Devos et al., 2006) (Table 
1). The solved molecular structures from various scaffold Nups show a high similarity to clathrin 
vesicle-coats and NTRs of importin- superfamily and have been predicted to have a common 
evolutionary origin (Brohawn et al., 2009). Based on their location in the NPC scaffold, these 
Nups have also been classified as the outer ring (Nup107-160 complex) and the inner ring 
(Nup205-Nup93 complex) Nups, however, this arrangement is controversial and a current topic 
of research in the field (Alber et al., 2007) (Brohawn and Schwartz, 2009) (Debler et al., 2008) 
(Amlacher et al., 2011). 
2.4.2.3. Permeability barrier forming nucleoporins 
The FG-repeats from FG-Nups radiate into the central channel and constitute the NPC 
permeability barrier (as discussed in section 2.4). These FG-Nups are incorporated into the NPC 
central channel through direct interaction with one or more scaffold Nups. The structured 
regions of FG-Nups are composed of protein interaction domains such as coiled-coils domains 
(Nup62·58·54 complex, Nup62·88·214) or autoproteolytic domains (Nup98) or RRM (RNA 
recognition motif) domains (Nup53) that mediate their interaction with the scaffold Nups (Devos 
et al., 2006) (Table 1). 
2.4.3. Nucleoporin subcomplexes as the NPC building blocks 
During mitotic disassembly of nuclear envelope, nucleoporins reside in the cytoplasm as 
biochemically defined subcomplexes and can be isolated as stable interaction assemblies from 
HeLa cells (Matsuoka et al., 1999) and mitotic Xenopus egg extract (Macaulay et al., 1995). 
Protein interaction studies between nucleoporins by antibody labeling (Pante et al., 1994), yeast 
genetic screens (Doye and Hurt, 1995) and biochemical fractionations (Schlaich et al., 1997) 
(Allen et al., 2002) (Bailer et al., 2000) etc. have revealed that Nups in the assembled NPCs also 
exist as multi-protein subcomplexes. These sub complexes get arranged around a cylindrical axis 
to give NPC its characteristic octahedral symmetry. Thus, nucleoporin subcomplexes act as 
architectural modules for NPC formation.  





Table 1: Domain architecture of different nucleoporins in the NPC 
Adapted from (Brohawn et al, 2009). Relative stoichiometries of Nups compared to Nup107-160 complex 
are indicated according to (Ori et al, 2013). See text for details. 
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2.4.3.1. NPC disassembly and reassembly from nucleoporin subcomplexes 
In higher eukaryotes, NPC disassembly occurs during NE breakdown at the early stages of 
mitosis. Several studies have shed light to series of events leading to NPC disassembly and 
reassembly but the process is not understood with complete clarity yet. Phosphorylation is 
known to play a key role in NPC disassembly. Nucleoporins exist in hyper-phosphorylated state 
in M-phase Xenopus extract compared to S-phase (Miller et al., 1999). Mitotic disassembly is 
brought into effect by action of several kinases particularly CDK1 kinases (supported by Nek 
kinases), which specifically phosphorylate Serine and Threonine residues in the Nups. Recently, it 
was reported that phosphorylation of Nup98 is an important step leading to mitotic disassembly 
(Laurell et al., 2011). The order of NPC reassembly post mitosis is more clearly understood than 
its disassembly. It starts by recruitment of Nup107-160 complex on chromatin, which binds 
through its DNA binding subunit ELYS. This is followed by recruitment of transmembrane Nup 
Pom121 and Nup93-205 complex (Dultz et al., 2008) For review see (Antonin et al., 2008; 
D'Angelo and Hetzer, 2008). NPC biogenesis during interphase requires the insertion of NPC in 
intact NE. Also, the lower eukaryotes with closed mitosis require NPC insertion into an intact NE, 
which follows different operating mechanisms than the post mitotic NPC assembly. Assembly of 
interphase NPCs studied using time-lapse microscopy revealed that new pores do not contain 
components from pre-existing pores, thus are synthesized de novo (D'Angelo et al., 2006). Live 
cell microscopy analysis showed that interphase NPC assembly is slower compared to post 
mitotic assembly (Dultz and Ellenberg, 2010). Thus, mechanistic differences exist between two 
processes and are a topic of ongoing research (Imamoto and Funakoshi, 2012) 
As depicted in Figure 1.4a, the major biochemically-defined subcomplexes present in the NPC 
include: 
2.4.3.2. Nup107-160 complex (Y-complex) 
The metazoan Nup107-160 complex consists of nine subunits – Nup133, Nup96, Sec13, Nup107, 
Nup85, Seh1, Nup160, Nup37 and Nup43 while the homologous yeast Nup84 complex has seven 
subunits in total comprising of Nup84, Nup120, Nup85, Nup145C, Sec13, Seh1 and Nup133 
(Boehmer et al., 2008). The complex appears to be present symmetrically in the NPC scaffold on 
both sides of the NE and is the most well characterized NPC subcomplex. Metazoan Nup107-160 
complex is thought to be an essential component for the NPC assembly as immunodepletion of 
Nup107-160 complex during in-vitro nuclear assembly reactions results in NE lacking NPCs 
(Walther et al., 2003). Both natively isolated and in-vitro constituted scNup84 complex show a Y-
shaped structure in EM (Siniossoglou et al., 2000) and the complex therefore, is also referred to 
as the Y-complex (Figure 1.4b). Both yeast and metazoan Y-complex share some structural 
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elements with COPII vesicle coat machinery such as α-helical structural folds and common 
components like Sec13. As a result a common evolutionary origin has been proposed (Brohawn 
et al., 2008). 
Most of the subunits of yNup84 complex have been crystallized and have been shown to contain 
α-helical solenoids or β-propeller domains. Although the arrangement of the subunits within the 
complex is clear, in the absence of inter-complex molecular interaction data, various models for 
the arrangement of yNup84 complex in the NPC have been proposed (Bilokapic and Schwartz, 
2012). The arrangement predicted by the Lattice model is based on shared similarity of scNup84 
complex with COP II vesicle coats. According to this model, two parallel rings of scNup84 
complex are arranged in a head-to-head fashion spanning the entire width of the NPC.  
This molecular arrangement of yNup84 complex stabilizes the membrane curvature of the NE in 
a manner similar to COPII vesicle coat machinery; however, the orientation and interaction of 
the inner ring complex in this model is unclear (Brohawn and Schwartz, 2009). The Fence-pole 
model based on the packing of subunits in the crystallized fragments of scNup84 complex 
proposes a head-to-tail arrangement of the complex in four concentric rings (Debler et al., 2008). 
However, the model is argues for promiscuous interactions between the subunits of the complex 
and proposes a dynamic arrangement of NPC scaffold where conformational changes in the NPC 
structure would occur in response to cargo passage (Hoelz et al., 2011). A third, computational 
model, based on the integration of available positional and interaction data of various Nups, 
predicts head to tail arrangement of the scNup84 complex in the NPC in two concentric rings. 
The model proposes presence of two outer rings and two concentric inner rings with linker Nups, 
scNic96 and scNup82 connecting the two rings (Alber et al., 2007). 
2.4.3.3. Nup93-Nup205 complex  
Some of the largest Nups that do not contain FG-repeats and are not a part of the Y-complex 
include Nup205, Nup188, Nup155, Nup93 and Nup53. Stoichiometric interactions have been 
reported between some of these Nups based on biochemical fractionations and yeast genetic 
screens (Aitchison et al., 1995) (Marelli et al., 1998) but the molecular interaction of the subunits 
with each other is much less understood than the Y-complex. These Nups connect with trans 
membrane Nups, peripheral Nups as well as outer ring Nups, therefore, the complex, altogether, 
is also referred to as the linker complex. Crystal structures from scNic96 (vertebrate Nup93), 
Nup170 (vertebrate Nup155), scNup192 (vertebrate Nup205) and scNup188 have revealed a 
stacked alpha-helical solenoid arrangement in these Nups, with flexible domains similar to NTRs 
(Schrader et al., 2008b) (Sampathkumar et al., 2013) (Andersen et al., 2013). Recently, ctNup53 
(Chaetomium thermophillum Nup53) and ctNic96 were shown to interact with large Nups 
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ctNup192 and ctNup170 with short, flexible motifs. Such short, flexible motifs connecting the 
nucleoporins in a subcomplex are proposed to be responsible for the overall plasticity of the NPC 
(Amlacher et al., 2011). 
 
  
Figure 1.4: NPC subcomplexes 
Current view of subcomplex arrangement in the NPC. In blue- scaffold Nups, red- FG Nups, yellow-
Transmembrane Nups, ONM- outer nuclear membrane, INM- inner nuclear membrane (Image prepared 
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In yeast, scNic96 co-purifies with Nsp1Nup49Nup57 complex (vertebrate Nup625854 
complex) (Grandi et al., 1993) where its N-terminal heptad repeats anchor Nsp1Nup49Nup57 
complex in the NPC presumably through coiled-coil interactions (Grandi et al., 1995a). In 
vertebrates, however, the majority of Nup93 exists in a stable complex with Nup205 (Grandi et 
al., 1997). 
 
2.4.3.4. Nup2148862 complex 
Nup214·88·62 complex (scNup159·Nup82·Nsp1) is exclusively localized at the cytoplasmic side of 
the NPC (Fornerod et al., 1997b). Both Nup62 and Nup214 contain FG-repeats and all three 
subunits are also predicted to contain coiled-coil domains similar to Nup62·58·54 complex (Table 
1). Nup214 plays an important role in the terminal steps of CRM1-cargo-RanGTP disassembly 
(Hutten and Kehlenbach, 2006) and contains a beta-propeller domain that provides interaction 
sites for mRNA export factors (Napetschnig et al., 2007). The complex has not been crystallized 
so far but presence of coiled-coil domains point towards a similar interaction as found in 
Nup62·58·54 complex. 
 
2.5. Various approaches to study nucleoporin arrangement in the 
NPC 
Studying the NPC in an atomic detail by any single technique has not been feasible mainly 
because of the challenge posed by its large size and hundreds of individual components. A high 
degree of modularity in the NPC structure, however, has allowed us to break down this large 
molecular puzzle into smaller pieces. As a result, solving the high-resolution structures of 
individual Nups and their subcomplexes by X-ray crystallography or NMR and fitting them in high 
confidence cryo-ET maps seems to be the most logical solution to the problem. The 
multidisciplinary approach followed in the field for structural characterization of NPC has been 
very successful and is discussed below. 
2.5.1.1. Nucleoporins stoichiometry 
The number of different nucleoporins present in the NPCs had been determined by mass-
spectrometry of enriched NPC fractions from yeast and rat hepatocytes almost a decade ago. In 
both studies, identical set of nucleoporins was found to be present (∼30) (Rout et al., 2000; 
Cronshaw et al., 2002). However, accurate knowledge of the number of copies of each Nup per 
NPC is limited with figures ranging from 8-48 copies per Nup in the NPC. As a result several 
models of Nup arrangement in the NPC exist. The picture is complicated by various other roles 
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attributed to the Nups besides the components of NPC architecture such as in gene regulation, 
DNA replication and so on (Bukata et al., 2013) loss of weakly interacting peripheral Nups during 
isolation procedures. Recently, cell-type dependent variations in NPC composition were 
addressed and relative stoichiometries of individual Nups in human NPCs were quantified more 
accurately using targeted mass spectrometry (Ori et al., 2013) (listed in Table 1). More such 
targeted studies are required to accurately decipher the copy numbers of different Nups in the 
NPC and their heterogeneity if any, in response to cellular regulation. 
2.5.1.2. High-resolution microscopy  
Super-resolution microscopy applied to fluorescently labeled NPC components has the potential 
of revealing intricate NPC details that are not visible so far by any other means. Lately, NPCs 
have been studied by various high-resolution microscopic techniques, such as three-dimensional 
structural illumination microscopy (3D-SIM), which showed distinct differential localization of 
Nups within the NPC (Schermelleh et al., 2008). Polarized fluorescence anisotropy 
measurements of GFP-tagged Nups in live cells has revealed relative orientation of the 
nucleoporins, based on which a certain model of Y-complex arrangement in the NPC has been 
confirmed (Kampmann et al., 2011). Recently, using single molecule particle averaging methods 
in super-resolution microscopy, a precise arrangement of the Y-complex in the NPC were 
reported (Szymborska et al., 2013). Similar studies when applied to other nucleoporin complexes 
can ultimately reveal many other relative nucleoporin arrangements in the NPC. 
2.5.1.3. X-ray crystallography 
High-resolution crystal structures are now available for a majority of Nups and their interaction 
complexes. ScNic96 (Nup93) (Schrader et al., 2008a), scNup192 (Nup205) (Sampathkumar et al., 
2013), scNup188 (Nup188) (Andersen et al., 2013) are among the largest Nups present in the 
inner scaffold ring whose structures have recently been solved successfully. All these protein 
exhibit alpha-helical solenoid like folds and flexible domains comparable to NTRs (Figure 1.4).  
All components of heptameric scNup84 complex have been crystallized (Bilokapic and Schwartz, 
2012). The complex is shown to be entirely built up from alpha-helical and beta-propeller 
domains with flexible-hinge regions. What remains to be seen is the configuration in which these 
proteins are arranged in the NPC.  
In this arrangement (Figure 1.4a), the structure of Nup62·58·54 complex is still missing. In fact, it 
is the least understood NPC subcomplex both at a biochemical as well as the atomic level and is 
described below.   
 
2. Introduction   
 
 27 
2.6. Nup625854 subcomplex 
Nup62 was the first nucleoporin described as a structural component of the NPC more than 25 
years ago when a punctate nuclear rim staining with a monoclonal antibody (mAB414) that 
recognizes Nup62 among other FG-containing Nups, was observed in the immunofluorescence 
microscopy (Davis and Blobel, 1986). The protein was later found to exist in a stable complex 
with two other FG-repeat containing NPC components, Nup58 and Nup54 (Finlay et al., 1991) 
(Kita et al., 1993).  
The Nup62·58·54 complex (homologous complex in yeast Nsp1·Nup49·57 complex) lines the 
NPC’s central transport channel (Grote et al., 1995). All three subunits of the complex contain 
FG-repeat domains at their N-terminus. In addition, Nup58 also has C-terminal FG-repeat 
domains. All FG-domains of the Nup62·58·54 complex contribute synergistically towards 
formation of the vertebrate NPC permeability barrier (Labokha et al., 2013). The FG-repeat 
domains of Nup62 are modified heavily by addition of N-acetyl glucosamine in vivo (Davis and 
Blobel, 1987) and as a result Nup62 is one of the main nucleoporins that binds WGA (Wheat 
germ agglutinin). The effect of this posttranslational modification on the structure of Nup62 was 
analyzed in baculoviral expression, where glycosylated Nup62 was shown to have the same 
structure as non-glycosylated Nup62 (Bailer et al., 1995). Thus, posttranslational modifications 
are not crucial for maintaining structure of Nup62 and have more functional roles such as 
regulating the NPC’s permeability barrier as in case of Nup98 (Labokha et al., 2013).  
The C-terminal coiled-coil domains of all three subunits in the Nup62·58·54 complex interact 
strongly with each other (Buss and Stewart, 1995). The coiled-coil domains are critical in 
mediating interactions between the subunits with each other as well as anchoring the complex 
to the NPC. Single amino acid substitutions in the heptad repeat in these coiled-coil domains 
were found to cause growth defect in yeast (Nehrbass et al., 1990). In yeast, the 
Nsp1·Nup49·Nup57 complex shows a strong interaction with scNic96 (yeast homolog of 
vertebrate Nup93). The regions responsible for this interaction have been mapped at the coiled 
coil domain containing N-terminus of scNic96 (Grandi et al., 1995b).  
Recently, Xenopus nuclei reconstitution experiments showed that depleting xlNup62·58·54 
complex from the NPC leads to formation of nuclei having slightly deviated morphology and a 
reduced nuclear transport (Hulsmann et al., 2012). It is also one of the last components 
assembled into the NPC’s structural backbone (Dultz et al., 2008). Thus, Nup62·58·54 complex 
has more functional roles in the NPC than imparting structural integrity. The complex being 
present at the inner most part of the NPC’s central channel can probably assume a more flexible 
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conformation compared to the more rigid scaffold Nups in the vicinity. This might be one of the 
reasons behind failed attempts to crystallize Nup62·58·54 complex so far.  
However, a partial rattus norvegicus Nup62·58·54 complex was assembled by Melcak and 
coworkers (Melcak et al., 2007), which formed protein concentration and salt dependent 
oligomeric assemblies in solution. These multimeric protein assemblies were proposed to be 
physiologically relevant in the context of the NPC. Small, 50-60 residues long fragments of Nup58 
and Nup54 have been crystallized (Melcak et al., 2007) (Solmaz et al., 2013) that showed crystal 
packing into homo oligomeric assemblies in different conformations. The same fragments also 
could be crystallized in hetero-oligomeric assemblies with each other (Nup54·58) (Solmaz et al., 
2011). Thus, a promiscuous interactions between the coiled-coil domains of Nup62·58·54 
complex subunits was shown that has been explained in terms of a ‘ring dilation and contraction’ 
model of the NPC to explain their physiological relevance (Solmaz et al., 2011) (Solmaz et al., 
2013). The model proposes dynamic instability of the Nup62·58·54 complex inside the nuclear 
pore complex, resulting in dynamic association and dissociation of Nup62·58·54 complex 
subunits from each other in order to dilate and constrict the NPC ring.  According to this 
mechanism, the changes in the NPC diameter brought about by such dynamic assemblies of 
Nup62·58·54 complex subunits can bring about changes in the NPC diameter in the range of ∼20 
nm sufficient to contract and dilate the NPC ring. 
Severe problems with this model exist. First, the authors do not take into account the extremely 
‘chopped off’ nature of the complex studied by them that does not contain all the predicted 
structured regions in the subunits. Since, coiled-coil domains are commonly known to engage in 
promiscuous interactions in the absence of right interaction partners, it is possible that the 
observed homo and hetero-oligomeric assemblies of the fragments are simply a consequence of 
missing interaction partners. Second, such a model is difficult to reconcile with the arrangement 
of scaffold Nups in the NPC that do not undergo such large structural arrangements. Third, the 
copy number and stoichiometry of Nup62·58·54 complex proposed by the model (128 copies of 
Nup62, 32 copies of Nup58 and 64 copies of Nup54) does not match the copy numbers actually 
observed by many of the proteomic studies (which generally predict 16-48 copies of each 
subunit) (Cronshaw et al., 2002) (Ori et al., 2013). Fourth, the regions covered in the structure 
constitute only about 40% of the total structured regions in the Nup62·58·54 complex and the 
contribution or arrangement of other coiled-coil domains in the complex is not taken into 
account. Hence, the structure from a complete Nup62·58·54 complex containing all the 
structured elements will be closer to the real Nup62·58·54 complex structure within the NPC, 
and is the focus of this work. 




2.7. The exportin CRM1 
CRM1 (or Xpo1) is an essential NTR belonging to importin-β superfamily, which exports a wide 
variety of cargoes out of the nucleus (Fukuda et al., 1997) (Stade et al., 1997; Fornerod et al., 
1997a). The range of cargo molecules exported by CRM1 ranges from small proteins such as 
snurportin 1 (SPN1) to large complexes such as 60S pre-ribosomal subunits and HIV genomic 
RNA (Fornerod et al., 1997a; Kehlenbach et al., 1998) (Güttler and Görlich, 2011). 
CRM1 recognizes short, leucine-rich peptide motifs as export signals in its cargoes, termed as 
leucine rich repeats (LRRs) (Kutay and Guttinger, 2005). The crystal structure of 
CRM1·RanGTP·snurportin complex (Monecke et al., 2009) elucidated that during cargo export, 
CRM1 forms a toroid ring with its N- and C-terminus in close proximity to each other. The ring 
encapsulates RanGTP at its concave surface towards the N and C-terminal HEAT repeats, which 
engage in extensive electrostatic interactions with Ran. In addition, a β-hairpin loop (called the 
acidic loop) originates from HEAT repeat 9 and extends into the middle of the CRM1 ring to dock 
RanGTP in its position. SPN1 binding occurs at the outer surface of CRM1 ring where alpha-
helical NES of SPN1 docks in the hydrophobic cleft (HC) formed by HEAT repeats 11 and 12 of the 
CRM1 ring (Figure 1.5). Thus, in contrast to other exportins where cargo and RanGTP binding 
occurs in close proximity to each other, CRM1 has spatially separated sites for binding of the 
two. The binding of the cargo outside the CRM1 ring also explains the basis behind recognition of 
huge variety of cargoes by CRM1 compared to other transport receptors (Monecke et al., 2009). 
Recently, the structural basis behind ability of CRM1 to bind wide variety of cargoes was 
deciphered (Güttler et al., 2010). Accordingly, the nature and spacing of the Φ residues in the 
NES is the determinant of the cargo recognition by CRM1. 
It is known that RanGTP binding to CRM1 increases its affinity for cargo binding by approx. 1000 
folds (Monecke et al., 2009). In the absence of a direct interaction between cargo and RanGTP in 
the export complex, this increase in affinity could only be explained by an allosteric mechanism. 
Therefore, it was proposed that conformational changes induced in CRM1 on RanGTP binding 
lead to structural changes in the hydrophobic cleft resulting in the cargo binding and vice-versa 
(Monecke et al., 2009). Later, crystal structures of CRM1 in disassembly complex with RanBP1 
and RanGTP revealed an intermediate CRM1 conformation where RanGTP binding induced 
conformational changes in the CRM1 hydrophobic cleft were observed (Koyama and Matsuura, 
2010). In this conformation, CRM1’s acidic loop adopted a compact conformation leading to 
closing of the hydrophobic cleft in the disassembly complex. Recently, structures of unliganded 
CRM1 from S.cerevisiae (Saito and Matsuura, 2013) and C.thermophillum (Monecke et al., 2013) 
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were reported, showing an overall extended conformation of free CRM1, a compact acidic loop 
and a closed hydrophobic cleft (Figure 1.5). In these structures, C-terminal helix of scCRM1 was 
shown to regulate CRM1 transition from extended to compact conformation on RanGTP binding. 
Molecular dynamics simulations have revealed that CRM1 in extended conformation is highly 
flexible and binding of RanGTP makes it rigid and compact (Dolker et al., 2013). 
So far, it is clear from the structural studies that CRM1 undergoes many conformational changes 
during its function as an export receptor.  However, the molecular details of events leading to 
these structural and conformational changes are not understood. As a part of this project, we 
aimed to identify critical CRM1 residues that may be involved in stabilizing ‘cargo-free’ and 
‘cargo-bound’ CRM1 conformations. For this, we looked into the evolutionary conservation of 
CRM1 and identified the residues that have been thoroughly conserved across eukaryotic clades. 
Mutating these residues will shed light on various conformational states that CRM1 adopts 
during its function as a transport receptor.  
 
 
Figure 1.5: Structure of the CRM1·RanGTP·SPN1 export complex and unliganded CRM1 
CRM1 conformation in the ternary CRM1·RanGTP·SPN1 export complex (left) and unliganded form (right) 
as observed in the respective crystal structures. Open hydrophobic cleft (green) and an extended acidic 
loop (red) in the CRM1 toroid ring (salmon) are observed in the CRM1·RanGTP·SPN1 export complex 
whereas a closed hydrophobic cleft and a compact acidic loop are present in the unliganded CRM1. For 
clarity, only the NES of bound SPN1 (blue) is shown. RanGTP (yellow) binds the inner surface of CRM1 ring. 
Adapted from Monecke et al, 2009 (left) and Saito et al, 2013 (right). 
 
2.8. About this work 
In this project, I studied the essential elements of the NPC architecture and function by 
biochemical analysis of Nup62·58·54 complex; a major NPC structural element and the functional 
characterization of the exportin CRM1, a major player in facilitated NPC translocation. The first 
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chapter describes our data on biochemical properties of xlNup62·58·54 complex and subsequent 
crystallization attempts for its structure determination. Here, we first addressed many 
conflicting questions in the literature about Nup62·58·54 complex’s stoichiometry in the NPC, 
published reports about its oligomerization behavior and the inter-subunit interactions. We then 
describe its interaction with Nup93, another nucleoporin thought to anchor Nup62·58·54 
complex into the NPC. The last part describes our approach to crystallize Nup62·58·54 complex 
by conjugating it to the nanobodies, and the initial crystallization trials.  
The second chapter describes the functional features of the exportin CRM1, an essential nuclear 
transport receptor in all eukaryotes.  The X-ray crystallographic structures of CRM1 in different 
functional complexes are already available but the overall mechanism by which CRM1 adopts 
various conformations in these complexes is unclear. We adopted a mutagenesis approach to 
study this phenomenon where we mutated CRM1 residues that are strictly conserved during 
eukaryotic evolution. Here, we describe the effects of these mutations on CRM1 function 
through different functional assays that can be related to stabilization of one or other CRM1 
conformations.
 
3. Results  
3.1. Biochemical and structural investigation of xlNup62·58·54 
complex 
3.1.1. Coiled-coil domains in xlNup62·58·54·93 complex 
It has been reported since a long while ago that the amphipathic α-helices of all three subunits 
of Nup62·58·54 complex contain heptad repeats (HR) characteristic of the coiled-coil domains 
(Grandi et al., 1995b). Coiled-coil domains are the special interaction motifs in proteins build up 
of HR units, which are typically comprised of seven residues numbered a-g. In double-stranded 
coiled-coils, heptad positions a and d are occupied by hydrophobic amino acids whereas the rest 
of the positions contain polar residues. Prediction algorithms such as COILS (Lupas et al., 1991) 
score each heptad position for coiled-coil forming propensity by comparing it to the sequences 
of known coiled-coil proteins and thereby predict coiled-coil domains in the protein sequences. 
We used COILS algorithm to predict coiled-coil domains in Xenopus laevis Nup62, Nup58, Nup54 
and Nup93. Figure 3.1a shows coiled-coil probability vs residue positions for three scanning 
window sizes (14, 21 and 28 residues) where short, intermediate and long stretches of alpha 
helices participating in coiled-coil interactions can be observed. In xlNup62·58·54 complex, 
almost the entire C-terminal structured region is predicted to form coiled-coils whereas in 
xlNup93, the extreme N-terminus shows weak coiled-coil forming propensity (along with other 
regions spread across the protein sequence). MultiCoil is another coiled-coil prediction algorithm 
that uses the similar approach to differentiate three-stranded coiled-coils from two-stranded 
coiled-coils (Wolf et al., 1997). We also analyzed all four subunits of xlNup62·58·54·93 complex 
for their trimer forming potential using MultiCoil. 
For xlNup62, the entire structured region (342-547) can be divided into five sub domains, CC1-
CC5, containing heptad repeats separated by flexible linker regions. The two central subdomains, 
CC2 and CC3, are longer (>28) and have high probability for coiled-coil interactions whereas the 
peripheral domain CC1 is shorter (∼21 residues) but still has high probability for coiled-coil 
domain interactions. The C-terminal end of Nup62 comprises of two small regions, CC4 and CC5, 
with weak propensity to form coiled-coils. MultiCoil predicted the second coiled-coil domain CC2 
to have strong trimeric coiled-coil propensity (Figure 3.1b). xlNup58 was predicted to have two 
large domains, CC1 and CC2, both with high probability to form coiled-coils.  




Figure 3.1: Coiled-coil domains in Nup62·58·54·93 complex 
a. Prediction of coiled-coil domains in Xenopus laevis Nup62, Nup58, Nup54 and Nup93 using COILS 
algorithm (Lupas et al, 1991). The program calculates coiled-coil forming probability per residue, which is 
plotted against the residue position in the sequence.14, 21 and 28 residue window lengths are shown in 
green, blue and red respectively. b. Domain organization of Xenopus laevis Nup62, Nup58, Nup54 and 
Nup93 showing FG-repeat, coiled-coil (CC), alpha-beta and alpha-solenoid domains. Coiled-coil domains 
with strong and weak coiled-coil forming propensity are depicted in red and green respectively. Regions in 
Nup62, Nup54 and Nup93 with strong trimeric coiled-coil forming propensity, as predicted by MultiCoil 
(Wolf et al, 1997) are underlined. 
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xlNup54 on the other hand, contains one large and one small domain (CC1 and CC2 respectively) 
with high coiled-coil forming propensity and two C-terminal domains with low coiled-coil 
forming potential which is similar to  xlNup62. Multicoil algorithm predicted a strong trimer 
forming potential for Nup54 CC2. xlNup93 N-terminus was predicted to contain four small N-
terminal domains, CC1-CC4, with low coiled-coil forming probability. The trimer forming 
potential was strong for Nup93 CC1 and CC2. Thus, all coiled-coil regions in xlNup62·58·54·93 
complex are not similar in their predicted interaction strength and oligomerization state.  
3.1.2. ∆FG-xlNup62·58·54 complex 
It was observed in our lab before that FG-repeats in xlNup62·58·54 complex are not necessary 
for the complex formation between its subunits and that a complex lacking FG-repeats is fully 
capable of incorporation into in-vitro assembled NPCs in Xenopus nuclei (Bastian Hülsmann, 
unpublished data). Based on this observation, the N-terminal boundaries of Nup62 and Nup54 
were determined and the sequence essential for complex formation was determined to be 
Nup62 (342-end) and Nup54 (146-end) respectively. As Nup58 also contains C-terminal FG-
repeats, its N-terminal boundary was determined by in-vitro incorporation assay while C-
terminus FG-region was removed based on sequence analysis resulting in the boundaries Nup58 
(265-490). xlNup62 and xlNup58 boundaries determined by in-vitro incorporation assay contain 
the entire coiled-coil structured regions predicted by COILS algorithm. In case of Nup54 an 
additional domain stretch of residues not predicted to form coiled-coils (146-372) was also 
required for complex formation. Secondary structure analysis of Nup54 predicts this region to be 
composed of α-helices and β-sheets (from here on referred to as Nup54 α/β domain). 
∆FG-xlNup62 (342-547) 
 







Figure 3.2: Secondary structure prediction for Xenopus laevis ∆FG-Nup62·58·54 complex 
a. ∆FG-xlNup62 (342-547) b. ∆FG-xlNup58 (265-490) c. ∆FG-xlNup54 (146-535). Secondary structure and 
disordered regions in Nup62·58·54 complex were predicted using Phyre2 secondary structure prediction 
tool. The program predicts protein secondary structure and disordered regions in the protein sequence 
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based on PSI-BLAST output. The program predicts all Nup62·58·54 complex subunits to be comprised of 
alpha helices (green) with interspersed disordered linker regions (question marks). Coiled coil domains 
predicted from COILS algorithm are underlined. In addition to coiled-coil forming alpha helices, Nup54 also 
contains an additional region made up of alpha helices and beta-strands towards its N-terminus, termed 
as Nup54α/β domain.  
 
The secondary structure and disorder prediction for xlNup62 (342-547), xlNup58 (265-490) and 
xlNup54 (146-590) (from here on referred to as, ∆FG-xlNup62·58·54 complex) are shown in 
Figure 3.2. All subunits appear to contain coiled-coil domains interspersed with disordered 
regions. The extreme C-terminal regions of xlNup58 and xlNup54 although structured, do not 
contain coiled-coil domains and were predicted to be flexible. For crystallization, ∆FG-
xlNup62·58·54 complex was expressed in E.coli. 
3.1.3. Co-expression with interaction partners is required for ∆FG-xlNup54 solubility 
To purify ∆FG-xlNup62·58·54 complex for crystallographic analysis, all subunits were cloned as 
His14-tagged constructs with protease cleavage sites in between and expressed in E.coli.  
 
 
Figure 3.3: Solubility of ∆FG-xlNup62·58·54 complex subunits 
Nup62 (342-547), Nup58 (265-490) and Nup54 (146-535) were expressed individually in E.coli and purified 
by Nickel-affinity chromatography followed by on-column protease elution. ∆FG-xlNup62 and ∆FG-
xlNup58 were moderately soluble (green asterisk marked bands in Lane 3, 7) while Nup54 was mostly 
insoluble (Lane 11). Purified proteins were obtained by on-column protease cleavage. The ∼15kDa shift in 
expressed and eluted protein size is due to removal of the His-Sumo-tag. Equal amounts nickel eluents 
were loaded on the SDS gel. "–", Uninduced; "ind", induced; "sol", soluble fraction; "El"- eluate after on-
column protease cleavage.  
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∆FG-Nup62 and ∆FG-Nup58 were found to be moderately soluble on expression and could be 
purified in sufficient amounts. ∆FG-Nup54 on the other hand, was found to be mostly insoluble 
(Figure 3.3). All attempts to obtain ∆FG-xlNup54 in a soluble form such as growth at low 
temperature (16°C), inclusion of solubility enhancing tags (ZZ, MBP) etc. did not enhance its 
solubility. 
In general, insolubility of heterologous proteins in E.coli can be attributed to several factors such 
as absence of eukaryotic folding machinery required for proper protein folding and stability, 
aggregation prone exposed hydrophobic surfaces on the protein of interest or increase in 
protein solubility limit during overexpression. Co-expression of subunits of a multi-protein 
complex or a protein with a chaperone has been shown before to have an effect on increasing 
protein solubility and stability in E.coli (Li et al., 1997) (Bross et al., 1993). Therefore, we 
designed multi-cistronic expression constructs for co-expression of ∆FG-Nup54 with ∆FG-Nup62 
and ∆FG-Nup58 in E.coli. We used a double-tag affinity purification method where the insoluble 
partner ∆FG-Nup54 was His14-tagged while its interaction partners ∆FG-Nup62 and ∆FG-Nup58 
had a N-terminal ZZ-tag. Both His14 and ZZ tags were followed by protease recognition sites (of 
brSUMO protease) to cleave off the affinity tags directly form the Ni+2 affinity matrix after 
protein binding. Binding the co-expressed proteins to Ni+2 column using the His14-tag on ∆FG-
Nup54 followed by on-column protease elution, led to specific elution of either ∆FG-Nup54 or 
proteins directly bound to ∆FG-Nup54 from the Ni+2 column. 
Interestingly, we found that ∆FG-Nup54 becomes greatly soluble on co-expression with ∆FG-
Nup62 or ∆FG-Nup58 indicating that these subunits provide interaction sites for ∆FG-Nup54, 
thus preventing its aggregation into the inclusion bodies. Both ∆FG-Nup54·62 and ∆FG-Nup54·58 
complexes were pulled out on Ni+2 affinity matrix by using the His-affinity tag on Nup54 (Figure 
3.4). The complexes were eluted by on-column protease cleavage using brSUMO protease. 
Roughly 1:1 stoichiometry of subunits was observed for ∆FG-Nup54·62 complex and 1:2 
stoichiometry for the ∆FG-Nup54·58 complex on the SDS-gel. Thus, co-expression can be used as 
a tool for expressing ∆FG-Nup54 in a soluble form, which also leads to formation of stable 
complexes between the subunits that can be purified efficiently from E.coli. 




Figure 3.4: Co-expression with interaction partners makes Nup54 soluble 
His14 brSumo-Nup54 (HisSm-Nup54) was expressed singly or co-expressed with ZZ brSumo-Nup62 (ZZSm-
Nup62) or ZZ brSumo-Nup58 (ZZSm-Nup58) on a compatible plasmid vector in E.coli. The bands marked 
with asterisks are the expressed proteins. As seen in lane 3, Nup54 is insoluble when expressed alone, but 
gets soluble when co-expressed with either Nup62 or Nup58 (lane 8 and 13 respectively). Nup54 elutes as 
a complex with Nup62 (Nup54·62) and with Nup58 (Nup54·58) after Ni+2 pull down and on-column 
protease cleavage. The shift in the band sizes in expressed and eluate fractions is due to the removal of 
corresponding His14-Sumo and ZZ-Sumo tags. “–”, Uninduced; “ind”, induced; “sol”, soluble fraction; 
“unb”, unbound fraction; El- eluate after on-column protease cleavage. 
 
3.1.4. xlNup58 and xlNup62 also engage in a direct interaction 
In various studies before, native Nup62·58·54 complex has been isolated from NE extracts of 
different cell types using various isolation procedures resulting in different stoichiometries of the 
isolated complex. The reported stoichiometries range from 4:1:4 (Finlay et al., 1991) to 1:1:2 
(Kita et al., 1993) (Buss and Stewart, 1995) for Nup62·58·54 subunits. A 1:1:1:1 (Guan et al., 
1995) stoichiometry has also been reported for Nup62·58·54·45 complex isolated form rat liver 
nuclei (Nup45 being alternative spliced version of Nup58 in rats). In yeast, however, using a 
combination of genetic tagging and deletion studies, a more consistent 1:1:1 stoichiometry of 
Nsp1·Nup49·57 complex has been reported (Schlaich et al., 1997; Grandi et al., 1995b) (Grandi et 
al., 1997). Individual subunits of scNsp1·Nup49·57 complex have also been recombinantly 
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expressed and purified from bacteria under denaturing conditions to reconstitute the complex 
(Bailer et al., 2001). Strong interactions observed between Nup54 and Nup62 (and the 
corresponding scNup57, scNsp1 subunits) in the reconstitution experiments under denaturing 
conditions have led to the view that Nup54 binds Nup62 and Nup58 directly (Buss and Stewart, 
1995). However, no direct proof of interaction between Nup62 and Nup58 have been reported 
so far. 
We co-expressed Nup62 and Nup58 in E.coli using the double affinity tag method (Figure 3.5). 
The purification was done under two different salt concentrations, at 50mM NaCl (low salt or ls) 




Figure 3.5: Direct interaction between Nup62 and Nup58 
Direct interaction between Nup62 (342-547) and Nup58 (265-490) was observed after co-expression using 
different tags under different salt conditions. The Nup62·58 complex could be pulled out using affinity tag 
on either subunit – His14 -tag on Nup62 and ZZ-tag on Nup58 (left) or in an alternate tag system using 
His14-tag on Nup58 and ZZ-tag on Nup62 (right) under two different salt conditions. “–”, Uninduced; “ind”, 
induced; “son”, sonicated fraction; “sol”, soluble fraction; “Ni+2 eluate”, fraction after imidazole elution 
from Ni+2 column; “ls”, low salt buffer 50mM NaCl; “hs”, high salt buffer 500mM NaCl. 
 
Under all the conditions tested, Nup62 and Nup58 interacted and formed a complex that could 
be pulled out using tag on either of the subunit. Salt concentration in the buffer (50mM or 
500mM) did not have any visible effect on the interaction indicating that the interaction was 
specific and stable. Therefore, we could establish that a direct interaction between Nup62 and 
Nup58 exists and that both are able to form a binary complex. However, on a prolonged 
incubation at 4°C for 2-3 days, the binary Nup62·58 complex showed a visible aggregation. In a 
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similar manner, although, Nup54 could be obtained in a soluble form by co-expression and 
binary complexes between Nup54·62 and Nup54·58 could be purified in high yields, these 
complexes were prone to form oligomers during gel-filtration. This tendency of binary complexes 
to aggregate and oligomerise indicated exposed hydrophobic residues on the surface of these 
subunits that most probably are the interaction sites for the absent third subunit. This also 
shows that in the absence of interaction partner the Nup62·58·54 complex subunits undergo 
promiscuous interactions leading to higher-order oligomers. 
3.1.5. A stable ∆FG-Nup62·58·54 complex can be purified under native conditions from 
E.coli after co-expression 
Next, we co-expressed all three subunits of ∆FG-xlNup62·58·54 complex together in E.coli to 
obtain a soluble complex for crystallization. ∆FG-Nup54 was present in a His-tagged form on a 
low copy vector (p15A; 10-12 copies/cell) while Nup62 and Nup58 were present as ZZ-tagged on 
a bicistronic vector with an intermediate copy number (30-40 copies/cell). On co-expression, 
Nup54 was present in the soluble fraction. Ni+2-affinity purification pulled out a trimeric ∆FG-
xlNup62·58·54 complex (Figure 3.6). The complex showed a clear 1:1:1 stoichiometry on SDS-gel. 
Thus, we could obtain large amounts of ∆FG-xlNup62·58·54 complex under native conditions 
from E.coli using co-expression. 
Since in these experiments, the amount of soluble Nup54 was limited by the presence of Nup62 
and Nup58 (which were present in excess over Nup54 due to solubility-enhancing ZZ-tag and 
presence on a high copy vector), virtually the entire Nup54 that was pulled out was in complex 
with Nup62 and Nup58. This was confirmed by gel-filtration and ion exchange chromatography, 
where protease cleaved Ni+2 eluent was directly loaded on the chromatography columns. The 
complex migrated as a single peak both in gel-filtration as well as in ion exchange and no 
dissociation of any subunit was observed (Figure 3.6b, 3.6c). This is consistent with the published 
data that native Nup62·58·54 complex isolated from nuclei is highly stable and can tolerate 
conditions such as 2M urea and detergent treatment indicating tight protein-protein interactions 
(Finlay et al., 1991). Thus, combining co-expression with on-column protease elution, we could 
reconstitute pure recombinant ∆FG-xlNup62·58·54 complex in E.coli in one-step purification. In 
cases where the complex was used for crystallographic analysis, gel filtration and ion exchange 
chromatography steps were included to obtain highest level of purity.  
 




Figure 3.6: Purification of ∆FG-xlNup62·58·54 complex 
a) Nickel pull down of ∆FG-xlNup62·58·54 complex from E.coli lysate using affinity tag on ∆FG-Nup54. The 
complex eluted after on-column protease cleavage shows stoichiometric amounts of Nup62, Nup54 and 
Nup58. The cleaved off ZZ-SUMO tag was separated from ∆FG-xlNup62·58·54 complex by gel-filtration. 
The complex also migrated as a single peak on ion-exchange column. b) Gel-filtration profile of ∆FG-
xlNup62·58·54 complex showing the peak fraction wrt molecular weight standard. The complex migrates 
at a position expected for 230kDa protein complex, which is more than double its theoretical MW 
94.7kDa, indicating a highly elongated complex. c) Ion-exchange profile of ∆FG-xlNup62·58·54 complex 
showing single peak elution of the complex. 
 
3.1.6. ∆FG-xlNup62·58·54 is an elongated complex with 1:1:1 stoichiometry 
During gel filtration chromatography, ∆FG-xlNup62·58·54 complex eluted much prior to its 
theoretical molecular weight. The complex migrates at a size of roughly 230kDa compared to its 
theoretical MW of 95kDa (assuming single copy of each subunit is present in the complex). This 
migration behavior indicated that either the native state of the complex is non-monomeric 
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where more than one copy of each subunit is present or the complex folds into a highly 
elongated non-spherical structure. 
In order to resolve this issue, we carried out size exclusion chromatography coupled Multi-angle 
light scattering and dynamic light scattering (SEC-MALS-DLS) analysis of ∆FG-xlNup62·58·54 
complex. The ∆FG-xlNup62·58·54 complex eluate from a gel filtration column was directly 
analyzed for its light scattering properties at different angles using different LS detectors in an 
online mode. This led to determination of absolute molar mass, root-mean square radius and 
hydrodynamic radius of the complex (Figure 3.7). The ∆FG-xlNup62·58·54 complex eluted as a 
single monodisperse peak (polydispersity of 1) from the gel filtration column indicating a 
homogenous species in terms of the MW. Mn (number average molar mass), Mw (weight 
average molar mass) and Mz (Z-average molar mass) for this peak are listed in the Table 2. The 
average molecular weight (Mavg) of this peak was estimated to be 95.2± 4.7 kDa. The value fits 
the scenario where a single copy of each subunit (sum of MW of subunits of ∆FG-xlNup62·58·54 
complex - 24.2(Nup62)+ 25.8(Nup58)+ 44.7(Nup54) equals 94.7 kDa) is present. The error limits 
in the predicted MW, thus allow only one copy of each subunit (i.e. 1:1:1 subunit stoichiometry) 
in the complex and any other stoichiometry would result in a MW far outside the error range of 
the measurement. These results also confirm the stoichiometry of 1:1:1 seen on SDS PAGE 
during purification of ∆FG-xlNup62·58·54 complex.  
 
 
Figure 3.7: Stoichiometry of ∆FG-xlNup62·58·54 complex determined by MALS 
a) Light-scattering signal from gel-filtration fractions of ∆FG-xlNup62·58·54 complex. The complex 
migrated as a single peak at an estimated MW of 95.2 ± 4.7kDa. The blue line indicates the UV signal 
(280nm) and in red is the LS trace recorded from LS detector at 90° angle b) Zoomed in version of the peak 
fraction showing Molar mass distribution. Solid line indicates trace from the RI detector while dashed line 









Table 2: Table showing properties of xlNup62·58·54 complex as determined by MALS analysis 
Table showing the estimated molecular weight, root mean square radius and hydrodynamic radius for 
∆FG-xlNup62·58·54 complex. “n”, number average; “w”, weight-average; “z”, Z-average distribution. 
 
3.1.7. Nup93 interaction with ∆FG-xlNup62·58·54 complex 
It has been reported that the N-terminus of scNic96 (the yeast homolog of mammalian Nup93) is 
directly involved in anchoring Nsp1·49·57 (yeast homolog of mammalian Nup62·58·54) complex 
to the NPC by coiled-coil interaction (Grandi et al., 1995b) (Bailer et al., 2001). In yeast deletion 
studies, N-terminal heptad repeats of Nic96 were shown to be responsible for interaction with 
Nsp1·49·57 complex while its central coiled-coil domains were found to be non essential for this 
interaction (Grandi et al., 1995b). In order to determine whether a direct interaction between 
xlNup93 and xlNup62·58·54 complex can be reconstituted in recombinant purified subunits; we 
co-expressed all four subunits of ∆FG-xlNup62·58·54·93 complex in E.coli. His-tag on Nup93 was 
used to pull out ZZ-tagged ∆FG-xlNup62·58·54 complex on Ni+2 matrix. When expressed alone, 
full-length xlNup93 was largely insoluble. Co-expression with Nup62·58·54 complex greatly 
increased the solubility of Nup93. The quaternary Nup62·58·54·93 complex could be stably 
expressed in E.coli and we could pull out the complex containing all four subunits together. Thus, 
we could reconstitute the quaternary ∆FG-xlNup62·58·54·93 complex by co-expression in E.coli 
in a similar manner as ∆FG-xlNup62·58·54 complex.  
On aligning the sequences of yeast and Xenopus Nup93 N-terminus, it was seen that the 
essential hydrophobic residues forming the heptad repeats are conserved in both organisms 
(Figure 3.8). In order to map the minimal domain in the N-terminus of xlNup93 (1-180) sufficient 
for interaction with Nup62·58·54 complex, we created ZZ-tagged constructs of different lengths 
in Nup93 N-terminus- Nup93N1 (1-82), Nup93N2 (1-95), Nup93N3 (1-157) and Nup93N4 (1-180). 
 We tested these constructs in the co-expression assay with His-tagged ∆FG-xlNup62·58·54 
complex and found that similar amounts of Nup93N-terminus were pulled out for Nup93N2 (1-
95), Nup93N3 (1-157) and Nup93N4 (1-180) whereas the amount of associated Nup93 N-
terminus slightly decreased for Nup93N1 (1-82). Therefore, we used xlNup93N2 (1-95) as the 
minimal interaction domain for purification of ∆FG-xlNup62·58·54·93n complex (Figure 3.8b). 
Molar mass moments (g/mol) Root mean square radius (Rms) 
moments (nm) 
Hydrodynamic radius (Rh) 
moments (nm) 
Mn 9.514X104 (±0.134%) Rn 4.6 (±28.1%) Rh(n) 5.1 (±4.3%) 
Mw 9.514X104 (±0.014%) Rw 4.6 (±28.1%) Rh(w) 5.1 (±4.3%) 
Mz 9.514X104 (±0.299%) Rz 4.6 (±28.1%) Rh(z) 5.1 (±4.3%) 
M (avg) 9.523X10
4 
(±0.005%) R (avg) 4.2 (±1.2%) Rh(avg) 5.0 (±0.5%) 





Figure 3.8: Mapping N-terminus of xlNup93 for interaction with ∆FG-xlNup62·58·54 complex 
a. Sequence alignment of X.laevis and S.cerevisiae Nup93 N-terminus. The conserved amino acids are 
shown in blue. The residues forming the heptad repeats of coiled-coil domains in both species are 
indicated from a-g (red). b. Deletion mapping of xlNup93 N-terminus for interaction with ∆FG-
xlNup62·58·54 complex. The constructs were created according to coiled-coil domain predictions (green) 
in xlNup93 N-terminus and co-expressed with ∆FG-xlNup62·58·54 complex in E.coli. The complex 
containing ZZ-tagged Nup93 N-terminus was pulled out using His-tag on Nup54. Based on this, the length 
of Nup93 N-terminus sufficient for ∆FG-xlNup62·58·54 complex interaction was determined to be residues 
1-95. “−”, uninduced; “ind”, induced; “Ni el”, Imidazole eluate after binding Ni+2 binding; “ls”- low salt 
(50mM NaCl) buffer, “hs”- high salt buffer (500mM NaCl). 
 
3.1.8. xlNup93 N-terminus has weak affinity for ∆FG-xlNup62·58·54 complex 
During purification of ∆FG-xlNup62·58·54·93n complex, Nup93n was often found to be in a sub-
stoichiometric amount than the rest of ∆FG-xlNup62·58·54 complex. When a complex containing 
excess of Nup93n over Nup62·58·54 complex was loaded on a gel filtration column, we observed 
that majority of Nup93n dissociated and ran as a separate peak and only a minor fraction 
migrated along with the ∆FG-xlNup62·58·54 complex (Figure 3.9a). In order to determine if this 
was the actual stoichiometry of the Nup62·58·54·93n complex or a result of weak affinity of 
Nup93n for ∆FG-xlNup62·58·54 complex, we loaded the peak fraction from the gel-filtration 
chromatography on a second gel-filtration column.  




Figure 3.9: xlNup93N-terminus has weak affinity for ∆FG-xlNup62·58·54 complex 
a. Gel filtration profile of ∆FG-xlNup62·58·54·93n complex. ∆FG-xlNup62·58·54·93n complex containing 
excess of Nup93n (1-95) was loaded on the gel filtration column. As seen in the corresponding SDS gel 
picture, Nup93n dissociated and migrated separately from the rest of the complex. b. Reloading the peak 
fraction from (a) on gel filtration column. xlNup93n, though sub-stoichiometric in amount, still dissociated 
from the rest of the complex, indicating a weak interaction. 
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Again we observed a similar behavior that the remaining Nup93N also spontaneously dissociated 
from ∆FG-xlNup62·58·54 complex (Figure 3.9b). Therefore, we could conclude that xlNup93 N-
terminus has a weak affinity for ∆FG-xlNup62·58·54 complex. When we compared the coiled-coil 
forming probability of vertebrate Nup93 (xlNup93 and hsNup93) with scNic96 and ctNic96, we 
observed that Nup93 N-terminus in fungi has stronger coiled-coil domain formation propensity 
compared to xlNup93. Therefore, we predict that there may be additional interaction sites on 
vertebrate Nup93 besides the N-terminus, responsible for anchoring the ∆FG-xlNup62·58·54 
complex in the NPC.  
The weak affinity of xlNup93n for ∆FG-xlNup62·58·54 complex was also analyzed by surface 
plasmon resonance (SPR) where xlNup93n was immobilized on a solid surface and ∆FG-
xlNup62·58·54 complex was allowed to bind it at different protein concentrations. The Kd value 
for this interaction was found 1.77µM (Figure 3.10). Thus, we could confirm that low values of 
affinity of Nup93 N-terminus for Nup62·58·54 complex accounted for losing Nup93n during 
purification of Nup62·58·54·93n complex. However, so far we could not purify full-length 
xlNup93 due to its poor solubility in E.coli. It would be interesting to compare the affinity of full-
length Nup93 with the coiled-coil domains at its N-terminus to determine if additional high 
affinity sites for Nup62 complex binding exist on Nup93. 
 
 
Figure 3.10: Affinity measurement for Nup93 N-terminus interaction with Nup62·58·54 complex 
Surface plasmon resonance analysis was performed, and the sensograms were obtained from injection of 
Nup62·58·54 complex at five concentrations (each in triplicate) over surface immobilized Nup93 N-
terminus. The complex was injected for 180 s and dissociation was monitored for 300 s. The Kd value for 
interaction was determined to be 1.77μM.  
 
3.1.9. Crystallization attempts for ∆FG-xlNup62·58·54 complex 
Crystallization trials for ∆FG-xlNup62·58·54 and ∆FG-xlNup62·58·54·93n complex did not yield 
any crystals despite broad range of conditions tested (∼4000 conditions for each). The failure in 
crystallization could be attributed to inherent flexibility of these complexes caused by internal 
linker regions or disordered ends of the subunits (Figure 3.2). To get Nup62·58·54 complex in a 
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more rigid form, we immunized camelids with the ∆FG-xlNup62·58·54·93n complex and obtained 
nanobodies against it. The sections below describe the expression, isolation and screening of 
nanobodies against ∆FG-xlNup62·58·54·93n and crystallization trials of nanobody conjugated 
∆FG-xlNup62·58·54 complex.  
3.1.10. Nanobodies (Nbs) against ∆FG-xlNup62·58·54 complex 
Nanobodies (Nbs) are ‘heavy chain only antibodies’ occurring in the family Camelidae that 
includes camels, llamas, guanacos, alpacas and vicuñas. The antigen-binding fragment in these 
single-domain antibodies comprises of only the variable domain of the heavy chain (referred to 
as VHH or variable domain of the heavy chain of heavy-chain antibody) instead of two domains 
(VH, for variable domain of heavy chain and VL, for variable domain of light chain) found in 
conventional antibodies (Figure 3.11a). These single domain fragments have been reported to 
express really well in bacteria and have been used in successful crystallization and structure 
determination of difficult proteins (Chung et al., 2011) (Lam et al., 2009).  
Since attempts to crystallize ∆FG-xlNup62·58·54·93n on its own failed, we raised nanobodies 
against it in order to find small high affinity binding partners that could stabilize the complex and 
aid in crystallization. High flexibility in the linker regions connecting the coiled-coil modules 
might be one of the reasons for not being able to crystallize the complex. Since nanobodies have 
been shown to make protein complexes rigid by binding to flexible conformations (Lam et al., 
2009), they might be good candidates for co-crystallization of Nup62·58·54·93n complex.  
We obtained 29 nanobody sequences against ∆FG-xlNup62·58·54·93n complex, which were 
cloned into bacterial expression vectors. Since nanobodies contain disulfide bonds as a part of 
their core framework, periplasmic expression in E.coli was used as a method of choice for their 
isolation. The purified nanobodies were then analyzed for the binding sites on Nup62·58·54·93n 
complex.  
 




Figure 3.11: Nanobodies against ∆FG-xlNup62·58·54 complex 
a. Schematic comparison of domain structure in classical antibodies with heavy chain antibodies found in 
camelids. Nanobodies are variable domains of heavy chain antibodies (VHH) harboring the entire antigen-
binding site (Adapted from Muyledermans, 2001) b. Crystal structure of GFP-GFP nanobody complex 
showing nanobody (red) binding to GFP (green) via CDR loops (Kubala et al, 2010) c. Phylogenetic tree 
from multiple sequence alignment of 29 nanobodies obtained against xlNup62·58·54·93n complex. The 




3.1.11. ∆FG-xlNup62·58·54 complex recognition by the nanobodies 
28 out of 29 nanobodies that could be successfully purified after bacterial periplasmic expression 
were tested for in-vitro binding to the purified ∆FG-xlNup62·58·54 and ∆FG-xl Nup62·58·54·93n 
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complexes. 24 nanobodies were found to recognize and pull out the ∆FG-xl Nup62·58·54 
complex (Figure 3.12). All nanobodies that bound ∆FG-xlNup62·58·54 complex pulled out similar 
amounts of ∆FG-xlNup62·58·54 complex (except Nb24 and Nb27, which bound weakly). We did 
not find any nanobody that could stabilize the interaction between xlNup93n and ∆FG-
xlNup62·58·54 complex in this analysis. In order to find suitable candidates for crystallization, the 
positive nanobodies were screened for their binding sites on ∆FG-xlNup62·58·54 complex. This 
was done in the pull-down experiments by incubating nanobodies with individual subunits of the 
∆FG-xlNup62·58·54 complex (Nup54 α/β domain, Nup62) or with the binary complexes 
(Nup62·58 and Nup62·54) 
 
 
Figure 3.12: All nanobodies bind ∆FG-xlNup62·58·54 complex with high affinity 
Binding assays showing pull-down of ∆FG-Nup62·58·54 complex with individual nanobodies. Nanobodies 
were mixed with equimolar amounts of ∆FG-Nup62·58·54 complex and incubated for 1h at room 
temperature. The complex was pulled down on Ni+2 beads using C-terminal His-tag on the nanobodies. 
Equal amounts of nickel eluate from each pull down were loaded on SDS gel. Each Nb, except Nb24 and 
Nb27, pulled out similar amount of ∆FG-xlNup62·58·54 complex. 
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3.1.12. Most nanobodies recognize Nup54 α/β domain in the ∆FG-xlNup62·58·54 complex 
In the screening for binding sites of Nbs on ∆FG-xlNup62·58·54 complex, 18 out of 24 
nanobodies recognized and pulled out α/β domain in Nup54 (Nup54 146-372). Thus, most of the 
nanobodies we obtained from immunization of Nup62·58·54 complex were directed against 
Nup54 α/β domain (Figure 3.13).  
 
Figure 3.13: Most nanobodies recognize xlNup54 α/β domain in the ∆FG-xlNup62·58·54 complex 
Binding assays showing recognition of Nup54 alpha-beta domain by most nanobodies. The nanobodies 
were incubated with GFP-Nup54 α/β domain and the complex was pulled out using His-tag on nanobodies 
on nickel beads. Unbound fractions (un) and nickel eluent (el) were loaded adjacent to each other on the 
on SDS gel. For most nanobodies GFP-Nup54 α/β domain was found in the eluent fractions. Lanes marked 
with arrows show nanobodies that do not recognize Nup54 α/β domain (Nb 13, 15, 19, 20, 22 and 27) and 
are interesting candidates for crystallization. (Elate is 5X more concentrated than the unbound fraction). 
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The reason for this can be higher immunogenicity of xlNup54 α/β domain compared to the 
coiled-coil domains of ∆FG-xlNup62·58·54 complex or selection bias for Nup54 α/β domain 
during phage display. We tested whether Nup54 α/β domain can be separated from the coiled 
coil regions of ∆FG-xlNup62·58·54 complex and purified on its own. Although highly soluble, 
Nup54 α/β domain heavily associates and co-purifies with E.coli chaperones (data not shown).  
gThis indicated presence of exposed hydrophobic sites on Nup54 α/β domain that might be 
shielded during its association with the coiled-coil domains of Nup62·58·54 complex. We could 
separate the associated E.coli chaperones from the Nup54 α/β domain on an anion-exchange 
column, but the resulting protein aggregated heavily, thus confirming that Nup54 α/β domain 
physically interacts with the rest of the Nup62·58·54 complex. 
3.1.13. Nanobody 15 recognizes the trimeric coiled-coil interface of ∆FG-xlNup62·58·54 
complex 
Four nanobodies (Nb15, 19, 20 and 22) were found to recognize exclusively the ternary coiled-
coil interface of ∆FG-xlNup62·58·54 complex. These nanobodies failed to bind the individual 
subunits (Nup62, Nup54 α/β domain) or the binary complexes (Nup62·58 or Nup62·54). Thus, 
they were specific for their binding to a coiled-coil interface that is formed only when all three 
subunits Nup62, Nup58 and Nup54 are present.  
Such conformation specific nanobodies are ideal candidates for co-crystallization because they 
stabilized the trimeric complex state of the Nup62·58·54 complex over the individual subunits. 
Also, since they themselves have a rigid fold, these nanobodies will further reduce the flexibility 
of coiled-coil domains improving chances of its crystallization.  
Sequence analysis of these trimeric coiled-coil conformation-specific nanobodies revealed that 
they belonged to two distinct classes. Nb15, 19 and 22 (trimeric coiled-coil interface class I) were 
very similar in their sequence and bound to the same site on the ∆FG-xlNup62·58·54 complex. 
This was observed in a binding assay where these nanobodies competed against each other for 
binding to ∆FG-xlNup62·58·54 complex. Nb20 on the other hand, had a distinct sequence from 
Class I nanobodies and recognized a second site on ∆FG-xlNup62·58·54 complex. These two 
classes of nanobodies were also compatible for simultaneous binding to Nup62·58·54 complex 
and could form a pentameric Nb15-Nb20-Nup62·58·54 complex (Figure 3.16e). Figure 3.14 
shows a comparison between recognition sites of Nb15 (representative of trimeric coiled-coil 
interface binding Nbs) and Nb2 (representative of Nup54 α/β domain binding Nbs). While Nb15 
solely recognizes trimeric state of Nup62·58·54 complex, Nb2 binds Nup62·58·54 as well as 
Nup62·54 and Nup54 α/β domain. 
 





Figure 3.14: Nb15 exclusively binds trimeric coiled-coil interface in ∆FG-xlNup62·58·54 complex 
Binding assays of Nb15 (representative of trimeric coiled-coil domain binding Nbs) and Nb2 
(representative of Nup54 α/β domain binding Nbs) with trimeric Nup62·58·54 complex, binary Nup62·58 
and Nup62·54 complexes, monomeric Nup62 and Nup54 α/β domain. Input fractions are loaded on the 
left while corresponding nickel eluent fractions bound to nanobodies are loaded on the right in each gel. 
Nb15 binds and pulls out only the trimeric Nup62·58·54 complex (lane 6), while Nb2 like all other alpha-
beta domain binding nanobodies, binds Nup54 α/β domain (lane20) and therefore, also pulls out trimeric 
Nup62·58·54 complex (lane16) and binary Nup62·54 complex (lane 17) but not Nup62·58 (lane 18) or 
Nup62 (lane 19). 
 
 
3.1.14. Crystallization of Nanobody conjugated ∆FG-xlNup62·58·54 complex 
We purified nanobody-conjugated ∆FG-xlNup62·58·54 complexes in large-scale preparations for 
crystallization trials. In brief, ∆FG-xlNup62·58·54 was purified as before by coexpression followed 
by on-column protease elution. Chromatographic purification with gel-filtration and ion 
exchange columns further polished the complex. E.coli periplasmically expressed Nbs containing 
C-terminal His6 tag were purified via Nickel chromatography and gel-filtration to remove 
aggregates and impurities. Purified Nup62·58·54 complex and Nbs were mixed in 1:1.5 molar 
ratio and incubated for 1h at RT. The complex between Nb and Nup62·58·54 complex was pulled 
out by Ni+2 affinity chromatography. Excess of nanobody was separated from complex by gel-
filtration, where Nup62·58·54 complex bound to Nb migrated as a single peak while excess of 
the free Nb came out in later elution fractions.  




Figure 3.15: Scheme for large-scale purification of nanobody containing ∆FG-xlNup62·58·54 complex 
See text for details 
 




Figure 3.16: Various nanobody - ∆FG-xlNup62·58·54 complexes screened in crystallization trials 
∆FG-xlNup62·58·54 complex conjugated to a. Nb15 (binds trimeric coiled-coil interface Class I) b. Nb2 
(binds Nup54 α/β domain) c. Nb15 and Nb2 d. Nb20 (binds trimeric coiled-coil interface Class II). e. Nb15 
and Nb20 f. Nb15, Nb2 and Nb13 (binds Nup62·54 interface). Gel filtration fractions after preparatory 
scale complex formation were loaded on SDS gel. 3C- input Nup62·58·54 complex, mix- Stoichiometric 
amounts of nanobody and Nup62·58·54 complex incubated for conjugation, El- Nup62·58·54 complex 
pulled out by nanobody on Nickel column g. Overlay of gel filtration profiles of Nup62·58·54 complex, 
Nup62·58·54 complex conjugated to single nanobody and Nup62·58·54 complex conjugated to two 
nanobodies showing corresponding shifts in the elution volume with increasing size of the overall 
complex. 





Continued from previous figure 
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The quality of Nb conjugated Nup62·58·54 complexes were determined by polydispersity 
measurement in QELS (Quasi-elastic light scattering). The fractions with polydispersity <15% 
were used for crystallization trials (Figure 3.15). For conjugation of two-or more Nbs to the 
Nup62·58·54 complex, the gel-filtration fractions from first conjugation were incubated again 
with the second nanobody and complex was directly applied to gel-filtration.  
The nanobodies screened in the crystallization trials included Nb15 (trimeric coiled-coil interface, 
Class1), Nb20 (trimeric coiled-coil interface, Class2), Nb2 (Nup54 α/β domain binder) and Nb13 
(Nup54·62 binder). In addition, the pentameric complexes Nb15-Nb20 Nup62·58·54, Nb15-Nb2 
Nup62·58·54, and Nb15-Nb13 Nup62·58·54 and hexameric Nb15-Nb13-Nb2 Nup62·58·54 were 
also tested (Figure 3.16).  
Nb20 that belonged to the second class of ternary coiled-coil interface binding nanobodies had a 
longer CDR3 loop compared to Class 1 nanobodies and contained an inter-loop disulfide bond 
between CDR2 and CDR3. This disulfide bond was found to be extremely reduction-sensitive and 
could be easily reduced in Nup62·58·54 complex bound Nb20. Thus, Nb20 was not a good 
candidate for crystallization even though it stabilized the ternary coiled-coil interface of 
Nup62·58·54 complex on account of heterogeneity introduced by its reduction-sensitive 
behavior. 
A full crystallization sparse-matrix screen comprising of ∼4000 crystallization conditions was 
tested for crystal formation. For Nb15-Nup62·58·54 complex, two hits obtained under two 
different conditions showed rod-shaped crystals (Figure 3.17). The crystals from one condition 
(37% Polypropylene-glycol 400, 15% ethanol) could be optimized in manual drop format. The 
diffraction from these crystals was however limited to 7.5Å resolution.  
3.1.15. Attempts to improve crystal diffraction 
Various standard methods used in protein crystallography were tested to improve crystal 
diffraction from Nb15- ∆FG-xlNup62·58·54 complex crystals. Additive screening (addition of 
small compounds in the crystallization drop), crystal dehydration (by transferring crystals into 
wells containing increasing concentrations of precipitants) (Heras and Martin, 2005) etc. was 
tried. However, no improvement in diffraction was observed with these methods. 
 




Figure 3.17: Rod-shaped crystals of Nb15- Nup62·58·54 complex 
Rod-shaped crystals of Nb15-∆FG-xlNup62·58·54 complex grown under different conditions. The crystals 
appeared after 2 days and grew to their maximum size in 1 week. The diffraction from these crystals, 
however, was limited at 7.5-Å resolution. 
 
3.1.16. Limited proteolysis of ∆FG-xlNup62·58·54 complex 
Limited proteolysis followed by mass-spectrometry is widely used approach in protein 
crystallization that is used to identify stable protein domains. Stable protein domains resistant to 
proteases tend to result in better-diffracting crystals. It is known that conformationally flexible 
or solvent exposed regions are favored sites of protease action leaving the rigid domain of 
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protein intact (Cohen et al., 1995). In order to define the boundaries of interacting coiled-coil 
domains in ∆FG-xlNup62·58·54 complex assuming that the interface regions remain intact during 
protease digestion, we performed limited proteolysis of ∆FG-xlNup62·58·54 and ∆FG-xlNb15-
Nup62·58·54 complex with chymotrypsin. Chymotrypsin was chosen since it has a broad-range 
of specificity compared to other proteases such as GluC. It cleaves at the C-terminal end of 
aromatic residues Tyr, Trp, Phe and Leu but also shows some cleavage at the C-terminal side of 
hydrophobic amino acids such as Met and Ile. Different time-points of chymotrypsin digestion 
over different substrate to protease amounts (1:100, 1:1000, 1:10,000 w/w) were screened to 
obtain a stable protease digestion pattern (Figure 3.18a). After optimizing the conditions for 
protease digestion, the pattern of stable bands that appeared is shown. Mass spectrometry 
analysis of digested fragments revealed that the C-terminal domains in all three subunits were 
sites of protease digestion (Figure 3.18c). These ends might be the regions where Nup93 
interacts Nup62·58·54 complex. In the absence of interaction partner (as Nup93n dissociated 
from Nup62·58·54 complex during purification), the flexible domains become available for 
protease action. The Nb15 conjugated Nup62·58·54 complex showed slightly different pattern 
for Nup54 digestion compared to the native complex (Figure 3.18b). Nanobody 15 binding might 
shield conformationally flexible regions on Nup54, protecting it from protease action.  
Next, large-scale preparation of Nb15-Nup62·58·54 complex was subjected to chymotrypsin 
digestion under optimized conditions. The digested complex was analyzed on gel-filtration to 
separate the protease-resistant complex. We observed a main peak comprising of Nb15-
Nup62·58·54 fragments running at size slightly smaller than the native complex. This was 
preceded by a pre-peak fraction, which were essentially the oligomers of Nup62·58·54 complex 
in a non-stoichiometric amount. Also, the two peaks could not be completely separated on gel-
filtration column (Figure 3.19). Thus, cleaving Nb15-Nup62·58·54 complex by the proteases 
induced oligomerization of the digested fragments indicating that the complex gets unstable on 
protease cleavage. Mass spectrometric analysis of digested fragments in the main peak revealed 
that mainly the C- terminal regions of all three subunits were cleaved off indicating that these 
might be the weak affinity sites in the complex, whose cleavage induces oligomerization of the 
remaining complex. 
 




Figure 3.18: Limited proteolysis of ∆FG-xl Nup62·58·54 complex with chymotrypsin 
a. ∆FG-Nup62·58·54·93n complex incubated with α-chymotrypsin in 1:1000 (w/w) protease: protein ratio. 
At indicated time intervals, samples were taken out and boiled in 1X SDS-sample buffer to terminate the 
reaction. Nup54 and Nup58 showed degradation into smaller fragments b. Comparison of chymotrypsin 
digestion pattern of xlNup62·58·54 complex with Nb15- xlNup62·58·54. Band marked with asterisk show 
the digestion product of Nup54 that might be shielded from protease action due to nanobody binding. c.  
Mass-spectrometry analysis of smaller fragments obtained by limited proteolysis. The bands were sliced 
out of the SDS-gel and analyzed by MALDI-TOF. Sequence in black and red indicate the missing and 
present regions respectively. Peptides for C-terminal domains of Nup54 and Nup58 were found to be 
mainly missing indicating that they are the major sites of protease digestion and might be exposed in the 
complex due to sub-stoichiometric amounts of Nup93. 
 
 




Figure 3.19: Gel-filtration of Nb15-∆FG-Nup62·58·54 complex after limited proteolysis with chymotrypsin 
a. Gel filtration profile of chymotrypsin digested Nb15-∆FG-Nup62·58·54 complex, showing the mixed 
population of partially digested Nb15-Nup62·58·54 complex (oligomeric peak) and the main peak 
corresponding to the smaller complex which could not be separated from the oligomers by gel filtration b. 
Mass-spectrometry analysis of digested Nup54, Nup62 and Nup58 showing protease sensitive regions 
(black) and protease resistant (red) domains. 
 
3.1.17. In-situ limited proteolysis 
In-situ limited proteolysis has also been shown to improve crystal diffraction of many proteins 
where addition of trace amounts of protease to the crystallization drop was shown to remove 
flexible N and/or C-terminal ends resulting in better crystal packing (Dong et al., 2007). The 
method is especially applicable in problematic cases where obtaining the protease-digested 
fragments in homogeneous form is difficult. We added chymotrypsin in trace amounts to the 
crystallization drop of Nb15-Nup62·58·54 complex (chymotrypsin: protein concentration ranging 
from 1:2000- 1:10,000) and performed the extensive sparse matrix screening for Nb15-
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Nup62·58·54 complex in the presence of the protease. This time we obtained a greater number 
of crystal hits than the previous screen (>10 out of 3000 conditions tested).  
 
Figure 3.20 In-situ limited proteolysis of Nb15 ∆FG-xlNup62·58·54 complex 
(a-b) Crystals obtained after in-situ limited proteolysis of Nb15-Nup62·58·54 complex. Trace amounts of 
chymotrypsin were added to the protein prior to setting crystallization drops. Multiple hits were obtained 
with different crystal morphology than obtained before for the non-proteolyzed complex. 
 
The morphology of crystals was different than before, as they were single rods or small 
cubes/plates compared to multiples needles observed with the non-proteolyzed Nb15- 
Nup62·58·54 complex before (Figure 3.20). These crystals however, were very small in size and 
stopped growing after 30-40 µm and hence, could not be used for crystallographic analysis.  
3.1.18. Cytosolic expression of nanobodies and Nup93n-Nb15 fusion 
The presence of disulfide bonds in the nanobodies poses a problem for their expression in 
bacterial cytoplasm, as it possesses an oxidizing environment. For this reason, periplasmic 
secretion signals have to be fused at the N-terminus of Nbs to transport them to the bacterial 
periplasm where disulfide bonds formation and protein folding occurs. This strategy though 
successful for obtaining large amounts of nanobodies, does not allow fusion of N-terminal bulky 
affinity tags or protease cleavage sites (e.g. ZZ-sumo tags). We therefore explores a bacterial 
strain (NEB SHuffle) for nanobody expression, which is capable of forming disulfide bonds in ts 
cytoplasm, thus overcoming the need of fusing periplasmic secretion signals. The strain lacks 
major cytoplasmic reductive pathways (trxB and gor pathways) and has a chromosomal insertion 
of the enzyme disulfide bond isomerase (DsbC). We found that nanobodies containing the N-
terminal fusion partners were extremely well expressed in this strain and did not show any 
degradation, indicating proper folding and correct disulfide bond formation (Figure 3.21). Thus, 
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we could circumvent the need for periplasmic expression for correct folding of nanobodies by 
expressing them in the SHuffle strain. This was an important outcome since we could now fuse 
these nanobodies with specific proteins such as GFP, protease recognition folds, ZZ or MBP 
solubility enhancer tags and other proteins to express them in bacterial cytoplasm without any 
major degradation problems. 
 
 
Figure 3.21: Bacterial expression of disulfide-bond containing nanobodies 
Comparison of periplasmic and cytosolic expression of Nb15 (in NEB express and NEB SHuffle strains). 
Periplasmic expression of nanobodies relies on N-terminal secretion signal and non-cleavable C-terminal 
His-tag (Scheme on the left) and in general could not be combined with bulky expression enhancing tags 
and protease cleavage sites (left gel panel). In the cytosol of conventional bacterial expression strains (NEB 
express for e.g.), nanobodies undergo degradation (lane 2-7) due to lack of disulfide bond formation. We 
identified that NEB SHuffle strain can be successfully employed for the disulfide bond formation in 
nanobodies, leading to stable final product (lane 8-9) (right gel panel). “His14 SM”, His14-brSUMO; “His14 
ND”, His-NEDD8; “CC-AV”, Disulfide bond forming Cys22 and Cys96 in the nanobody framework mutated 
to Alanine and Valine; “CC-VA”, Disulfide bond forming Cys22 and Cys96 in the nanobody framework 








Figure 3.21: Nanobdy 15 fusion to Nup93n (1-95) and optimization of spacer lengths 
(a-c) Gel-filtration profiles of Nup62·58·54 complex conjugated with Nup93-Sp-Nb15. Effect of different 
spacer lengths between Nup93n and Nb15 on oligomerization of Nup62·58·54 complex were observed. 
Excess of Nup62·58·54 complex was incubated with Nup93n-sp-Nb15 (mix) to promote intra-complex 
incorporation of Nup93n into the Nup62·58·54 complex. With a short spacer of 5 residues (Nup93n-Sp5-
Nb15), Nup93n is not incorporated into the Nup62·58·54 complex and leads to inter-complex interactions 
causing oligomerization (left). With a longer spacer length of 10 residues (Nup93-Sp10-Nb15), however, no 
oligomerization was observed indicating that Nup93n is incorporated in to the Nup62·58·54 complex. The 
corresponding gel filtration fractions are shown in the SDS gel below. d. Crystals obtained for Nup93N-
Sp10-Nb15 conjugated Nup62·58·54 complex using in-situ limited proteolysis with chymotrypsin. 
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Nup62·58·54 complex has interaction sites for Nup93n but owing to their weak affinity towards 
each other (as shown in Section 3.1.8), the interaction is not stable. Crystallization of Nup93N-
terminus with Nup62·58·54 complex however is important to understand its anchorage in the 
NPC. In order to achieve this aim, we tried to stabilize Nup93n in the Nup62·58·54 complex by 
fusing it in-frame to the Nb15 with a short flexible linker in between. This fusion would prevent 
its spontaneous dissociation from the Nup62·58·54 complex and might enhance the chances of 
its crystallization. 
We fused Nup93n (1-95) to the N and C-terminus of Nb15 and used this fusion to incorporate 
Nup93n into the Nup62·58·54 complex. We tested the effect of two different linker lengths (5 
and 10 residues) between Nb15 and Nup93n. We also tested the effect of different orientations 
of Nup93 N-terminus with respect to Nb15 by fusing it to either at the N- or the C-terminus of 
Nb15. Interestingly; we found that fusion of Nup93 at the N-terminus of Nb15 (Nup93-Sp-Nb15) 
were better behaved than the C-terminal fusions (Nb15-Sp-Nup93) in single expression. 
Therefore we proceeded with complex formation between Nup93n-Sp-Nb15 (LSp-Long spacer 10 
residues, SSp- short spacer 5 residues) and Nup62·58·54 complex. 
Conjugation of Nup93n-Sp-Nb15 to Nup62·58·54 complex revealed that a long spacer length (10 
residues) between Nup93n and Nb15 (Nup93n-Sp10-Nb15 conjugated to Nup62·58·54 complex) 
migrated as a single peak on the gel filtration column (Figure 3.21b). With a short spacer length 
between Nup93n and Nb15 (Nup93n-Sp5-Nb15) two peaks were observed after Nup62·58·54 
complex binding (Figure 3.21a). One migrated at the native complex position preceded by pre-
peak indicating soluble oligomers. Such oligomerization can be caused by failure of Nup93n to 
correctly incorporate into Nup62·58·54 complex due to smaller linker length. Free Nup93n thus, 
might engage in inter-complex interactions with another Nup62·58·54 complex unit causing 
oligomerization. The Nup93n-Sp10-Nb15 Nup62·58·54 complex containing incorporated Nup93N 
was then purified in large-scale for crystallization trials. Crystals were obtained for this complex 
after in-situ limited proteolysis and are currently limited in their size for X-ray diffraction.  
Thus, we could crystallize nanobody conjugated Nup62·58·54 complex and found a way to stably 
incorporate Nup93 N-terminus into the complex by fusing it to the nanobodies. Obtaining better 
diffracting crystals for both these complexes is a part of the ongoing work. For this, we aim to 
combine various approaches based on limited proteolysis, construct optimization and routinely 
used crystallographic methods such as micro seeding. We are also exploring more nanobodies 
that could stabilize trimeric Nup62·58·54 complex conformation further and aid in better crystal 
packing. The structure of Nup62·58·54 complex will bring us very close to completing the 
inventory of crystallized NPC components. 
 
 
3.2.  Mutational analysis of the exportin CRM1 
3.2.1. Strong evolutionary conservation of 20 residues in CRM1 
As described in the introduction, CRM1 belongs to the Importin-β superfamily of transport 
receptors, which are characterized by the presence of HEAT repeats as a constituting structural 
element. A single HEAT repeat unit comprises of two antiparallel α-helices (of 10-20 residues 
each) connected together by a short linker loop. The α-helices on the convex outer surface are 
termed as ‘A-helices’ while the ones forming the concave inner surface are termed as ‘B-helices’. 
In yeast as well as mammals, CRM1 structure is made up of 21 HEAT repeat elements stacked in 
a superhelical arrangement. This overall structural conservation of CRM1 is also true at the 
sequence level with 96% of residues being identical in human and fish (D.rario) CRM1. 
We analyzed CRM1 sequence from 58 diverse organisms starting from lower eukaryotes such as 
Trichomonas till humans including diverse eukaryotic clades such as plants and fungi (Figure 4.1). 
Any bias due to overrepresentation of any particular clade was avoided by selecting only single 
orthologues from similar sequences (by Thomas Güttler). The analysis revealed 20 CRM1 
residues to be strictly conserved throughout the evolution. No substitutions in these residues 
was observed anywhere in different classes of organisms. Since, CRM1 is overall a very strongly 
conserved NTR and is essential in both the lower as well as higher eukaryotes, conservation of 
these 20 residues throughout evolution suggests their importance in CRM1 function. Therefore, 
we separately mutated each of these 21 residues into closely related amino acids to study the 
effect of such subtle mutations on CRM1 function.  
3.2.2. Analysis of CRM1 point mutants 
Figure 4.2 shows the distribution of the absolutely conserved CRM1 residues in its structure. 10 
out of 20 residues are present in the hydrophobic cleft. The remaining residues are distributed in 
the other parts of CRM1 structure with P427 being present in the hinge region of the acidic loop. 
The mutations in all these residues were carefully designed in pymol, to prevent any drastic 
changes in the overall CRM1 structure. All mutants were expressed in E.coli and purified under 
similar conditions. For some residues in the hydrophobic cleft, more than a single mutation was 
designed to identify the residues that can be tolerated. Inside the nucleus, CRM1 binds RanGTP 








Figure 4.1: Sequence analysis of CRM1 from diverse eukaryotic species 
Phylogenetic tree showing CRM1 sequence identity in different eukaryotic species. CRM1 sequences from 
58 indicated species were analyzed for sequence identity. The tree was obtained by neighborhood joining 
method using percentage identity after ClustalW sequence alignment. 
 
Therefore, in order to analyze the functional significance of these mutations binding assays were 
performed in two sets where a) Binding to PKI-NES (Protein kinase inhibitor-nuclear export 
signal) in the presence and absence of RanGTP Q69L (5-180) was observed and b) Binding to 
RanGTP Q69L (5-180) in the presence and absence of PKI-NES was analyzed. (RanGTP Q69L 5-180 
is C-terminally truncated GTPase deficient form of Ran). 
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PKI-NES (LALKLAGLDI), a classical leucine rich NES was one of the first export signals recognized 
for CRM1-mediated export. We used N-terminal His-ZZ tag fusions of PKI-NES to immobilize it on 
IgG sepharose. Binding assays were then performed for the wild type CRM1 and CRM1 mutants 
in two parallel binding reactions. One set of binding mix contained RanGTP Q69L 5-180 in the 
binding mix, whereas the other did not contain it. In this manner, the functional role of these 
mutants for RanGTP/cargo cooperativity was studied. In an alternative scheme, ZZ-tagged 
RanGTP Q69L 5-180 was immobilized on IgG matrix and binding was performed in the absence 
or presence of PKI-NES. RanGTP Q69L. 
 
Figure 4.2: Distribution of evolutionary conserved residues on mmCRM1 
Structure of mmCRM1 in the export complex (blue) showing distribution of evolutionary conserved 
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3.2.3. CRM1 mutants stabilized in high affinity, cargo-binding state 
Certain conserved residues in CRM1 when mutated resulted in a stronger cargo binding. These 
mutants can be grouped under two classes based on RanGTP and cargo binding cooperativity. 
The first class comprised of mutants where cargo binding was strong and the RanGTP-cargo 
binding cooperativity was lost (G502A/S, P427G). These mutants bound PKI-NES much stronger 
than wild type both in the absence or presence of RanGTP (Figure 4.3). G502 is located in the 
HEAT repeat 10B surrounding the HC whereas P427 is present in the hinge region of the acidic 
loop 9. Both these mutants probably have a permanently open hydrophobic cleft that can bind 
the cargo but is incapable of closing thereby preventing cargo dissociation. If this was true, such 
mutants with open HC should also be compatible with Ran-binding.  
 
 
Figure 4.3: Cargo-binding of CRM1 mutants in the absence and presence of RanGTP 
20µl IgG beads saturated with immobilized ZZ-tagged PKI-NES were incubated with 1µM CRM1 in binding 
buffer (50mM Tris-HCl pH 7.5, 300mM NaCl) in the presence or absence of 1µM RanGTP Q69L (5-180) and 
1X E-mix. Complex formation was allowed for 2-3h at 4°C under shaking conditions. The proteins bound to 
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Indeed we observed that RanGTP binding was stronger in these mutants and they bound Ran 
both in the absence or presence of cargo, again indicating a permanently open hydrophobic cleft 
or nuclear conformation (Figure 4.4). 
The second class of mutants bound cargo stronger than the wild-type CRM1 but in a RanGTP 
dependent fashion (E513D, Q550N, Y551F, F554Y, M583L). These mutants bound PKI-NES much 
stronger than the wild-type CRM1 in the presence of RanGTP and also showed a weak binding in 
absence of RanGTP (Figure 4.3). Thus, these mutants probably stabilized CRM1 in cargo-binding 
conformation than its cargo free conformation. This was also observed when they bound 
RanGTP in the absence of PKI-NES (indicating a partially open HC) and showed increased RanGTP 
binding in the presence of the cargo (Figure 4.4). Another set of mutants that bound cargo 
strongly than the wtCRM1 included F366M and Y788F. These residues lie far away from the 
hydrophobic cleft in CRM1 structure and their effect cannot be explained based on the changes 
in the acidic loop and C-terminal helix. Therefore, these residues might be crucial in stabilizing 
the distinct conformations of CRM1. 
In HeLa nuclei live export assay, the mutants that bound PKI-NES strongly and showed no 
RanGTP-cargo cooperativity (G502A/S, P427G) failed to exclude cargo (GFP-tagged PKI) from the 
nuclei (Figure 4.4). It is quite possible that as these mutants bind cargo permanently without 
dissociation, they fail to carry out multi-round export across NPCs leading to cargo accumulation 
in the nucleus. On the other hand, the mutants that bound PKI-NES strongly and also exhibited 
RanGTP-cargo cooperativity (E513D, Q550N, Y551F, F554Y, M583L, F366M and Y788F) were 
functional in the export assay since they excluded fluorescently labeled cargo from the nucleus 
at a level comparable to wild-type CRM1 (Figure 4.5). Whether these mutants exhibit any export 
defect or not can be more stringently analyzed by studying live nuclei export kinetics or affinity 
measurements to determine cargo association and dissociation rates. 
 




Figure 4.4: RanGTP binding of CRM1 mutants in the presence or absence of cargo 
20µl IgG beads saturated with immobilized ZZ-tagged RanGTP (5-180) were incubated with 1µM CRM1 in 
binding buffer (50mM Tris-HCl pH 7.5, 300mM NaCl) in the presence or absence of 1µM PKI-NES and 1X E-
mix. Complex formation was allowed for 2-3h at 4°C under shaking conditions. The proteins bound to IgG 
beads were eluted after thorough washing in 1X SDS sample buffer and analyzed on SDS-gel. 
 
3.2.4. CRM1 mutants stabilized in low affinity, cargo-free state 
 Interestingly, mutations in the conserved residues that lie outside the hydrophobic cleft (L80I, 
W91F, E176Q, F179M, L625I and D1071A) were not tolerated.  These mutants failed to bind PKI-
NES or RanGTP in the binding assay indicating a loss in function (Figure 4.3, 4.4). This clearly 
indicates the functional importance of the conserved residues in stabilizing various CRM1 
conformations. However, to establish that these mutants are structurally intact and are indeed 
functional, we performed binding with a very strong cargo (super-PKI, or S-PKI). S-PKI has been 
previously shown to bind so strongly to the HC that it could force CRM1 into a nuclear 
conformation leading to loss of RanGTP-cargo binding cooperativity (Güttler et al., 2010). These 
mutants bound super-PKI in a manner similar to the wild type, indicating that indeed the 
structure of these mutants is intact, however, though due to subtle mutations, they were 
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Figure 4.5: Comparison of Super-PKI and PKI binding of low affinity CRM1 mutants 
CRM1 mutants with low binding affinity for PKI-NES were tested for binding to a stronger cargo (Super-PKI 
II NES) in the absence and presence of RanGTP. All mutants bound super PKI NES (upper and lower right 
panel) with similar affinity both in presence and absence of RanGTP indicating that they can be forced to 
adopt nuclear conformation in the presence of a strong cargo. 
 
3.2.5. CRM1 mutants with a blocked hydrophobic cleft 
Hydrophobic cleft is the most conserved site in overall CRM1 structure mainly because it is the 
site where NES-containing export cargo-recognition and binding occurs. Any mutation in the HC 
that prevents cargo binding either by steric hindrance or loss of free binding energy is bound to 
be deleterious to CRM1 function. Many of the conserved residues were located in the HC (A541, 
I544, M545, K568, F572, A584, M583) and exchanging them to other residues was not tolerated. 
The only exception was M583L, which is present at the base of the HC where an increase in 
cargo binding compared wild type CRM1 was observed. Strong mutations such as A541E/R/Y, 
I544K, K568E/R/L/M did not show any PKI or RanGTP binding in the binding assays as well as 
there was no export in HeLa nuclei. Subtle mutations at these sites such as A541T, I544A/T, 






















































































































































Figure 4.6: Export assay in HeLa nuclei for high affinity, RanGTP independent CRM1 mutants 
a. HeLa cell nuclei were incubated with high speed Xenopus egg extract (undepleted or Phenyl-sepharose 
depleted) in the presence of Ran-regenerating system and 1µM wild-type CRM1/CRM1 mutants for 20 
minutes before addition of 4µM GFP-tagged PKI-NES. The nuclei were further incubated for 10 minutes at 
room temperature to allow active export. Confocal sections from imaging in the GFP-channel are shown. 
GFP tagged PKI_NES exclusion was observed in HeLa nuclei incubated in undepleted Xenopus egg extract 
due to export by endogenous CRM1, while nuclear accumulation was observed in case of phenyl 
sepharose depleted extract. Addition of wild-type CRM1 led to complete exclusion of cargo from the 
nucleus. b. Export assay in HeLa nuclei incubated in Phenyl-sepharose depleted Xenopus egg extract with 
addition of indicated CRM1 mutants. Cargo accumulation in nucleus was observed for all three mutants- 
G502A, G502S and P427G indicating export incompetence of these mutants.  
 












Figure 4.7: Export assay in HeLa nuclei for high affinity, RanGTP dependent CRM1 mutants  
Export assay in HeLa nuclei pre incubated in Phenyl-sepharose depleted Xenopus egg extract in the 
presence of Ran-regenerating system and 1µM indicated CRM1 mutants for 20 minutes. 4µM GFP-tagged 
PKI-NES were added and further incubated for 10 minutes. All the mutants above efficiently exported 




Figure 4.8: Export assay in HeLa nuclei for low affinity CRM1 mutants 
Export assay in HeLa nuclei pre incubated in Phenyl-sepharose depleted Xenopus egg extract in the 
presence of Ran regenerating system and 1µM indicated CRM1 mutants for 20 minutes. 4µM GFP-tagged 
PKI-NES were added and further incubated for 10 minutes. These mutants were also found to export cargo 
out of the nucleus. 
 










Figure 4.9: Export assay in HeLa nuclei for CRM1 mutants with blocked hydrophobic cleft 
Export assay in HeLa nuclei pre incubated in Phenyl-sepharose depleted Xenopus egg extract in the 
presence of Ran regenerating system and 1µM indicated CRM1 mutants for 20 minutes. 4µM GFP-tagged 
PKI-NES were added and further incubated for 10 minutes. Cargo-accumulation in the nucleus was 

































A541E A541R A541Y I544K
































P427G Acidic loop **** * Dead 
G502A Surrounding HC **** *** Dead 
G502S Surrounding HC **** *** Dead 
E513D Surrounding HC **** * Active 
E513Q Surrounding HC ** * Active 
Q550N Surrounding HC *** *** Active 
Y551F Surrounding HC *** ** Active 
F554Y Surrounding HC *** **** Active 
M583L Base of HC *** * Active 
F366M Ran-binding 
domain 
*** *** Active 
Y788F Between Ran 
and cargo 
binding domain 
*** *** Active 
L80I Ran-binding 
domain 











< − Active 
E176Q Ran-binding 
domain 
− − Active 
F179M Ran-binding 
domain 
− − Active 
L625I Between Ran 
and cargo 
binding domain 
< < Active 
D1017A Between Ran 
and cargo 
binding domain 
− − Active 










A541T Base of HC < * Active 
A541R Base of HC − * Dead 
A541Y Base of HC − * Dead 
I544K Base of HC − − Dead 
I544T Base of HC < * Active 
I544A Base of HC < * Active 
M545A Base of HC − − Active 
K568E Wall of HC − * Dead 
K568R Wall of HC − * Dead 
K568L Wall of HC − * Dead 
K568M Wall of HC − − Dead 
F572Y Wall of HC − − Active 
A584V Base of HC − − Active 
 
Table 3 Table summarising the properties of CRM1 mutants 
“*”, Binding compared to the wild-type CRM1; one star indicates similar level of binding as the wild type, 
two, three and four stars indicate higher levels of binding than the wild-type with four stars indicating the 




Eukaryotic nuclear pore complex is a fascinating nanostructure that has been functionally and 
structurally conserved throughout the evolution and acts as the sole mediator of 
macromolecular exchange across the nuclear envelope. The giant machinery with a MW 
∼120MDa in humans and ∼60MDa in yeast is made up from 30 different subunits (nucleoporins), 
which assembles together into a highly symmetrical supramolecular structure, with octahedral 
symmetry in the plane of the nuclear envelope. In the last decade, molecular structures of a 
large number of nucleoporins and nuclear transport receptors have been described. Most of the 
nucleoporins exhibit a combination of super α-helical solenoid folds and β-propeller domains, 
which deviate strongly from other protein structures in the PDB. Not just the architectural 
elements of the NPC are structurally conserved; the key players involved in nucleo-cytoplasmic 
transport process also exhibit a distinct morphology that has been conserved throughout the 
evolution in different organisms. A large number of nuclear transport receptors belonging to the 
Importin-β superfamily (such as Importin-β and CRM1) have an alpha-helical solenoidal domain 
organization. All these NTRs shift between a cargo loading and cargo release state in response to 
RanGTP binding and traverse through the NPC by interacting with the FG-repeat domain 
containing Nups. With the high-resolution structures emerging for both the NPC structural 
elements (i.e. scaffold forming nucleoporins) and the functional players involved in nucleo-
cytoplasmic transport (i.e. soluble NTRs), it is becoming evidently clearer that the two might 
share a common evolutionary origin. An inherent structural flexibility is also emerging to be a 
common feature of both, with it being more pronounced in the soluble NTRs that undergo rigid 
body conformational changes during their role as macromolecule shuttles across the NPC. Many 
NTRs including CRM1 have been crystallized in complex with RanGTP and/or cargo as the binding 
of the interaction partners imparts the structural rigidity to the overall exportin structure, 
favoring crystallization. Nucleoporins on the other hand exist as a part of large stable 
subcomplexes and as a result have been crystallized with their interaction partners in order to 
achieve homogeneity and structural rigidity required for crystallization. Nup62·58·54 
nucleoporin complex forms part of the NPC central channel that contributes considerable mass 
of FG-repeats required for the formation of NPC’s permeability barrier. The exportin CRM1 on 
the other hand, overcomes this transport barrier by interacting with the FG-repeats and adopts 
different conformations in cargo bound or cargo free form during the translocation events. The 
crystal structure of CRM1 in different functional complexes is known whereas that of 
Nup62·58·54 nucleoporin complex is not available so far.  
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4.1.1. Insights into the molecular behavior of the Nup62·58·54 complex 
The Nup62·58·54 nucleoporin complex contributes a considerable share of the NPCs FG repeat 
mass and it is undisputed that it is crucial for the transport function of NPCs in a variety of 
organisms including S.cerevisiae and Xenopus laevis. Considering this, the existing literature is, 
however, surprisingly controversial in describing this complex. The controversies concern the 
number of Nup62·58·54 complexes per NPC, the stoichiometric ratio between the three subunits 
(Nup62, 58, 54 in metazoans; Nsp1p, Nup57, Nup49 in S.cerevisiae), the question as to which of 
the three subunits make direct contacts with each other, the question as to whether the 
Nup62·58·54 complex oligomerizes and if such oligomerization is physiologically relevant or an 
experimental artifact. The last question is also related to a mechanistic debate, namely if the 
Nup62 complex mediates facilitated translocation by dilating and contracting the NPC’s central 
channel in response to shifts in homooligomeric contact sites, as suggested by Melcak and 
coworkers (Solmaz et al., 2013; Solmaz et al., 2011; Melcak et al., 2007) or if it supports the 
permeability barrier by contributing barrier-forming FG domains. In this project, we could 
answer many of these questions in an unambiguous manner especially those concerning 
Nup62·58·54 complex stoichiometry and its oligomerization behavior. Our experimental data 
directly contradicts the Nup62·58·54 complex behavior in the NPC argued by (Solmaz et al., 
2011), which is solely based on the alternative interactions observed for the fragments of Nup62, 
Nup58 and Nup54 in the crystal structures.  
4.1.1.1. A clear 1:1:1 stoichiometry of the xlNup62·58·54 complex 
In various studies, different modes of isolation of Nup62·58·54 complex from different nuclear 
envelope preparations have resulted in contradictary observed stoichiometries of Nup62·58·54 
complex. The picture is further complicated by the fact that in these preparations a fourth 
protein at 45 kDa co-purifies with the rest of the complex. In earlier studies it was reported to be 
the proteolytic product of Nup58 while later on suggested to be an alternatively spliced isoform 
of Nup58. The isoform is exclusive to rats and does not exist in other organisms.  
To highlight the observed discrepancies in vertebrate Nup62·58·54 complex stoichiometry, a 
∼550kDa Nup62·58·54 complex in 4:1:4 ratio (Finlay et al., 1991) and a ∼234kDa Nup62·58·54·45 
complex with 1:1:1:1 subunit ratio (Guan et al., 1995) were isolated after detergent treatment 
whereas a 1:1:2 subunit ratio of ∼231kDa (Kita et al., 1993) and ∼400-500kDa (Buss and Stewart, 
1995) Nup62·58·54 complex was isolated on high salt treatment of the nuclear envelopes.  
The picture is more clearer in yeast where genetic tagging and biochemical fractionation has 
revealed 1:1:1 stoichiometry of the Nsp1·Nup49·57 complex (Grandi et al., 1995b) (Bailer et al., 
2001). Considering the overall architectural conservation of NPCs in yeast and higher eukaryotes, 
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it is difficult to imagine the reasons behind such divergence in the nucleoporin ratios in different 
organisms and is most likely a consequence of different technical procedures. 
In our experiments with recombinant co-expression and isolation, a 1:1:1 stoichiometry of 
Nup62·58·54 complex from X.laevis was found to be highly reproducible. The fact that the 
complex was assembled inside E.coli in the presence of thousands of other E.coli proteins and an 
identical subunit ratio was pulled out (in the SDS gel pattern) each time indicates that this indeed 
is the real stoichiometry for the Nup62·58·54 complex. The ratio is consistent with the proteomic 
studies (Cronshaw et al., 2002; Ori et al., 2013) where a 2:1:1 stoichiometry of Nup62, Nup58 
and Nup54 has been reported. Considering Nup62 is part of another nucleoporins complex 
(Nup62·88·214) as well, a 1:1:1 stoichiometry of Nup62·58·54 complex fits the scenario. Multi-
angle light scattering experiments confirmed this stoichiometry where the observed molecular 
mass of the complex perfectly matched the theoretical mass when single copy of each subunit is 
present.  
4.1.1.2. Oligomerization of Nup62·58·54 complex- real or artifcats? 
A ‘dynamic’ Nup62·58·54 complex assembled by Melcak et al (Melcak et al., 2007) showed 
protein concentration dependent oligomeric assemblies in solution. These assemblies were 
postulated to be physiologically relevant in context of the nuclear pores. It was argued that 
macromolecular transport driven large-scale conformational changes could be induced in the 
NPCs due to dynamic association and dissociation of the Nup62·58·54 complex. Even when one 
was to assume this was true, the copy number of the subunits in their model with 128 copies of 
Nup62, 32 copies of Nup58 and 64 copies of Nup54 (4:1:2 stoichiometry) is extremely large and 
cannot be reconciled with any other study nor with the arrangement of other nucleoporin 
complexes in the NPC. The main reason of the dynamic behavior of Nup62·58·54 complex 
observed by Melcak et al could be the partial nature of the complex studied by them. The 
oligomer forming Nup62·58·54 complex studied by them did not contain Nup54 α/β domain and 
the long coiled-coil domain of Nup58 (Nup58 CC1). Understandably so, this dynamic complex 
failed to crystallize.  
The xlNup62·58·54 complex assembled by us is significantly larger than the previously studied 
complex. The fact that it contains all the structural elements of Nup62·58·54 complex including 
Nup54 (Nup54 α/β domain) and the first coiled-coil domain of Nup58 (Nup58 CC1) makes this 
complex as close as it can get to the native FG-repeat containing Nup62·58·54 complex. In fact, 
all these structural domains were found to be absolutely essential during in-vitro Nup62·58·54 
complex assembly and its incorporation into the Xenopus NPCs (Bastian Hülsmann, unpublished 
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data). Small deletions of 5-10 residues from the N-terminus of any subunit in the assembled 
xlNup62·58·54 complex resulted in loss of complex formation.  
We did not observe any oligomeric tendencies in xlNup62·58·54 complex. In fact, the complex 
could be diluted significantly and concentrated to upto 20mg/ml for crystallization without 
observing any dynamic oligomers (as judged by its gel-migration behavior and polydispersity 
analysis). The complex was found to be monomeric in MALS analysis. 
Thus, we propose that the interactions observed by Melcak et al are most likely physiologically 
irrelevant or are an experimental artifact owing to the severely ‘chopped off’ nature of the 
studied complex. The behavior of Nup62·58·54 complex has great implications on our 
understanding of NPC architecture especially when a ring contraction and dilation model has 
been proposed for NPC channel based on these interactions.  
4.1.1.3. Interaction amongst the subunits of Nup62·58·54 complex 
While a direct interaction between Nup62·54 and corresponding scNsp1·Nup57 is well 
established (Bailer et al., 2001) (Buss and Stewart, 1995) no direct experimental evidence exists 
for Nup62 interaction with Nup58. The current model of vertebrate Nup62 complex 
arrangement (Buss and Stewart, 1995) (Solmaz et al., 2011) advocates Nup54 as platform 
providing separate binding sites for Nup62 and Nup58 interaction. In our co-expression system, 
we could address this question and to our surprise discovered that a direct interaction between 
Nup58 and Nup62 indeed exists. The two interacted strongly and pulled each other out from 
E.coli lysate during co-expression. However, the binary Nup62.58 complex was aggregation-
prone in the absence of Nup54. The observation is further strengthened by the fact that deleting 
the proposed interaction region on Nup54 for Nup58 (Solmaz et al., 2011), a trimeric 
Nup62·58·54 complex still assembled (data not shown), possibly due to a direct interaction 
between Nup62 and Nup58. Furthermore, we also obtained nanobodies that recognized a 
trimeric xlNup62·58·54 complex exclusively and failed to bind the binary Nup62·54 or 
Nup62·Nup58 complexes. Since, nanobodies are known to bind specific conformations in small 
regions of their target proteins, this suggests a direct Nup62·58·4 interaction or at least a 
conformational proximity of Nup62 and Nup58 which can not be explained by separate binding 
sites of Nup62 and Nup58 on Nup54. 
4.1.2. Nup62·58·54 complex anchorage to the NPC 
Most physical features of NPCs are conserved in yeast and higher eukaryotes (except smaller size 
of yeast NPCs ∼66kDa compared to human NPCs ∼120kDa). However, a basic cell-cycle 
difference exists between the two in terms of their behavior during mitosis.  S.cerevisiae 
undergoes closed mitosis where both the nuclear envelopes as well as the NPCs stay intact 
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throughout the mitotic process and no disassembly of NPCs into individual components occurs. 
In higher eukaryotes such as Xenopus and humans, nuclear envelope breakdown is an essential 
process required for chromosomal segregation and includes NPC’s disassembly into soluble 
nucleoporin subcomplexes. In higher eukaryotes, Nup62·58·54 complex exists as a separate 
entity in the mitotic cytosol physically disassociated from Nup93 (Macaulay et al., 1995), which 
interacts strongly with another nucleoporins and exists as Nup93·205 subcomplex. The yeast 
Nic96-Nsp1 subcomplex in contrast, never disassembles. In S.cerevisiae, it is well established that 
N-terminus of Nup93 containing coiled-coil domains is responsible for Nsp1 complex integration 
into the NPC scaffold. Deletion of 200 residues at the N-terminus of Nup93, which harbors 
coiled-coil domain forming heptad-repeats, results in loss of interaction between scNic96 and 
scNsp1 complex and associated growth defects in the strains carrying Nup93N-terminal deletion. 
However, surprisingly limited amount of data exists for vertebrate Nup62·58·54 complex 
anchorage to the NPC. Biochemical extraction of Nup93 and Nup62 from HeLa extracts showed 
that only a fraction of the two proteins associate together (Grandi et al., 1997). Whether this 
could be attributed to a loss of protein interaction during isolation procedure owing to weak 
interactions or the actual stoichiometry of the Nup93-Nup62 complex in vertebrates has never 
been studied. Furthermore, whether Nup93 coiled-coil domains are the only interaction sites for 
Nup62 complex in the NPC, as described for yeast, is not known.  
We looked into the interaction between N-terminal coiled-coil containing region of recombinant 
xlNup93 and xlNup62·58·54 complex in-vitro and discovered that an inherently weak interaction 
between the two exists. In our experiments, we could specifically pull out Nup62 complex using 
affinity tag on Nup93 N-terminus and vice-versa. The fact that this interaction occurs in E.coli 
cytosol suggests it to be highly specific. However, spontaneous dissociation of Nup93 from the 
rest of the complex during successive purification steps indicated a weak interaction, different 
from the coiled-coil interaction within Nup62 complex that was found to be stable in all tested 
conditions. Our experiments suggested the Kd values of affinity of Nup93 N-terminus for Nup62 
complex to be in the order of 2μM. Such low affinity for interaction might be relevant in the 
context of NPC where the concentration of the constituents is in the range of 200μM. 
Alternatively, additional anchorage sites for Nup62·58·54 complex in the NPC might be present 
that have not been discovered yet. 
Based on domain topology, xlNup62·58·54 complex differs from scNsp1·Nup49·57 complex in 
that it contains an additional region of ∼200 residues at the N-terminus of Nup54 coiled-coil 
domains that is predicted to fold into α helices and β-sheets (Nup54 α/β domain). This domain, 
as mentioned above, was missing in the complex assembled by (Melcak et al., 2007) that showed 
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high oligomeric tendencies. Also, we obtained many nanobodies directed against this domain, 
indicating that it might be more exposed or hydrophilic than the rest of the coiled-coil domains. 
We propose that this domain might be an additional anchorage site for the vertebrate Nup62 
complex in the NPC. 
The dissociation of nucleoporins subcomplexes from each other during mitosis, in general, is 
poorly understood at a molecular level. Although phosphorylation of Nups is known to be 
involved in this process, presence of multiple phosphorylation sites on each Nup complicate the 
study for determining the target sites for phosphorylation and resulting dissociation. The process 
can only be studied in higher eukaryotes and not in yeast. Such a direct weak interaction for 
vertebrate nucleoporins belonging to two separate subcomplexes has not been described 
before. One possibility to easily disassemble NPC is to evolve multiple sites of weak interaction 
between the nucleoporin subcomplexes that can be easily disrupted during mitosis resulting in 
formation of stable entities that reside in cytosol until NPC reassembles. 
4.1.3. Nanobodies as tools for co-crystallization of Nup62·58·54 complex 
With the crystal structures available for many nucleoporins, internal flexible loops or hinge 
regions in the Nups, appear to be a recurring theme. These have been observed in the crystal 
structures of subunits of scNup84 subcomplex, large inner ring Nups (scNup192, scNup188, 
scNic96, scNup170) and even smaller Nups (scNup53). Flexibility in the domains hampers 
crystallization, and as a result, many of these structures (scNup192, scNup188, scNup170, 
subunits of scNup84 complex) have been solved partially by crystallizing the stable domains only. 
We explored the potential of small, high affinity binders called nanobodies that have a rigid 
scaffold, for stabilizing potentially flexible Nup62·58·54 complex and aiding in its crystallization. 
Nanobodies have the potential for co-crystallizing entire nucleoporins because of their rigid 
scaffold where binding in the flexible domains of Nups could reduce their flexibility. But this 
strategy has not been tried for Nups so far although it has proven to be successful for co-
crystallization of some of flexible parasite domains.  
Other advantage of using nanobodies is that the conformation specific nanobodies can be easily 
obtained by customizing the panning strategy during phage-display. Since, we screened for the 
entire Nup62 complex binders during phage display and not for its individual subunits, the 
nanobodies obtained were reflective of the conformation its subunits adopt in the context of the 
complex. Also, different nanobodies recognize different binding sites on the Nup62·58·54 
complex and were screened for in-vitro binding to the Nup62·58·54 complex to find the most 
stabilizing ones. 18 out of 24 nanobodies were directed against Nup54 α/β domain, indicating 
that this domain is not shielded in the Nup62 complex. Out of the remaining nanobodies, four 
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nanobodies bound exclusively to trimeric Nup62 complex and did not recognize its individual 
subunits or any combination of binary complexes. This indicated that the nanobodies bind a site 
in the Nup62·58·54 complex where all three subunits interact closely with each other. Thus, 
these nanobodies stabilize the conformation of trimeric Nup62·58·54 complex and also probably 
rigidify the flexible nature of the complex. 
4.1.3.1. Nanobody mediated crystallization of Nup62·58·54 complex 
Our attempts to crystallize Nup62·58·54 complex did not succeed after exhaustive trials. 
However, crystallization trials of Nup62·58·54 complex conjugated to Nb15 led to immediate 
crystallization of this complex. The crystals appeared after 2 days and reached their maximum 
size in 1 week. Thus, conjugation of Nup62·58·54 complex with Nb15 clearly helped in its 
crystallization. Moreover, this positive effect on crystallization of Nup62·58·54 complex was 
observed only for Nb15 (that stabilizes the trimeric Nup62·58·54 complex state) and not with 
other nanobodies (e.g. the ones that bind the Nup54 α/β domain or Nup62·54 binary complex). 
This indicates that it is indeed the flexibility in the coiled-coil regions of Nup62·58·54 complex 
that hampered its crystallization. Nb15 binding to a flexible region in the coiled-coil domains 
might rigidify it allowing crystal packing. Rod-shaped crystals obtained for this complex are 
currently limited in their diffraction potential to 7.5Å. However, this is the first successful 
crystallization of the entire structured region of Nup62·58·54 complex so far. Attempts to 
improve the crystal diffraction potential are ongoing.  
In a similar manner, nanobody conjugation approach can also be applied to other NPC 
subcomplexes, whose crystal structures are not available yet. One such example is Nup62·88·214 
complex, which also contains coiled-coil domains as their constitutive elements and probably 
have similar flexible domains. Other examples are large Nups such as scNup192, which have 
been crystallized partially and the structures of their rigid domains are available whereas 
information for the hinge regions connecting these domains is completely missing. 
4.1.3.2. Exploiting nanobodies for stabilizing Nup93 interaction with Nup62·58·54 complex 
Inherent weak affinity of Nup93N-terminus coiled-coil domains for the Nup62 complex (as 
described in Section 3.1.8) posed a problem for the structural determination of 
Nup62·58·54·93ncomplex. Spontaneous dissociation of Nup93n during purification and in the 
crystallization drops led to sample heterogeneity and failure to understand this complex at a 
molecular resolution. In the absence of any published biochemical data on the subunits of 
Nup62·58·54 complex interacting with Nup93n, we adopted an unbiased approach for 
integrating Nup93n into the Nup62·58·54 complex structure by fusing it to Nb15. However, to 
obtain this, we first had to establish a successful expression system for nanobodies in the 
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bacterial cytoplasm. Traditional approach for nanobody expression in E.coli has relied on their 
periplasmic expression. The reason for this is the presence of disulfide bonds essential for 
maintaining the core structural framework of the nanobody scaffold. The periplasmic expression 
however, does not allow too much flexibility in the construct designs. We achieved a high yield 
of correctly folded nanobodies by exploiting NEB SHuffle strain (Section 3.1.18). Using this 
approach, we managed to successfully obtain high yields of cytoplasmically expressed 
nanobodies fused to partner of choice. In our case, this fusion product involved an expression 
enhancing tag with a bulky protease cleavage site and in frame fusion of Nup93 with varying 
linker lengths in between. By optimizing linker lengths and orientation of fusion partners in the 
final products, at he end, we were able to successfully incorporate Nup93n into the Nup62·58·54 
complex (Section 3.1.18).  
4.1.4. Mechanism of cargo-RanGTP cooperativity on CRM1 
CRM1 (or XPO1) is an essential nuclear transport receptor involved in exporting hundreds of 
structurally unrelated cargoes out of the nucleus. The versatility in CRM1 function is rooted in 
the unique manner in which it binds its cargoes compared to other commonly known transport 
receptors. In comparison to the other known exportins such as CAS, Exportin-t and Exportin-5, 
where the export cargo interacts directly with both the exportin and RanGTP, CRM1 export 
complexes show no direct interaction between the cargo and RanGTP (Güttler and Görlich, 
2011). Cargo-recognition site in CRM1 has been shown to be located in a narrow pocket formed 
by HEAT repeats 11A and 12A, on the outer surface of CRM1 ring, that is lined mainly by the 
hydrophobic (Φ) residues and is thus referred to as the hydrophobic cleft (or HC) (Monecke et 
al., 2009). A majority of export substrates bind CRM1 through a 10-15 residue long peptide 
stretch that fits into the rigid Φ pockets formed by the Φ residues of its HC (Güttler et al., 2010). 
RanGTP binding occurs on the inner surface of CRM1 near the N and C-terminal helices. CRM1 
binds RanGTP and cargo in a cooperative manner as it was observed that CRM1 binding to 
RanGTP increases its affinity for cargo binding by ≈ 1000 fold and vice-versa. In the absence of a 
direct interaction between RanGTP and cargo in CRM1 export complex, how is this cooperative 
binding achieved has been an intriguing question in the field. To explain this nature, an allosteric 
mechanism for RanGTP-cargo cooperativity on CRM1 was proposed where binding of RanGTP on 
the inner surface of CRM1 induces changes in its overall conformation bringing it to a 
conformational state compatible with cargo binding. Recent structural characterizations of 
CRM1 in different functional complexes, that include structures of the ternary 
CRM1RanGTPSPN1 export complex (Monecke et al., 2009), intermediate CRM1SPN1 (Dong et 
al., 2009) and CRM1RanGTP (Güttler et al., 2010) complexes, cytoplasmic CRM1RanGTPRanBP1 
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disassembly complex (Koyama and Matsuura, 2010) and unliganded scCRM1 (Saito and 
Matsuura, 2013) have revealed many features of this allosteric mechanism of RanGTP-cargo 
cooperativity. 
An ‘open’ hydrophobic cleft as observed in the CRM1RanGTPSPN1 export complex and the 
intermediate CRM1SPN1 and CRM1RanGTP complexes is a conformation CRM1 adopts in order 
to accommodate and bind the cargo-NES in the HC. In contrast, in the crystal structures of the 
CRM1RanGTPRanBP1 disassembly complex (a complex that forms during cargo-unloading stage 
of CRM1 when Υ-phosphate in RanGTP is hydrolyzed by concerted actions of RanBP1/BP2 and 
RanGAP), a relatively ‘closed’ HC conformation was observed. Similar closed HC conformation 
was also present in the crystal structure of free or unliganded scCRM1and ctCRM1. From these 
structures, it has become clear that the ‘opening’ and ‘closing’ of the HC during cargo and 
RanGTP binding/unbinding events is a consequence of overall conformational changes in CRM1.  
One of the structural rearrangements in CRM1 that is readily visible is the conformational 
change in the beta-hairpin loop present at the base of HEAT repeat 9 (termed as acidic loop due 
to the acidic residues present at its tip that interact with RanGTP in the export complex). The 
acidic loop adopts an extended conformation in the cargo-bound CRM1 and a compact, ‘flipped-
back’ conformation in cargo-free CRM1. Another local structural change observed in these 
crystal structures is the arrangement of the last α-helix in CRM1, the HEAT repeat 21B. In the 
cargo-bound state, this C-terminal helix is stacked parallel to other HEAT repeat helices in the 
CRM1 ring (as observed in the export complexes) whereas in the cargo-free state, it is oriented 
away from the toroid, extending to the center of the ring and touching the base of the HC. 
Overall, it is clear from above studies that CRM1 is stabilized into two distinct conformational 
states during the transport process, a cargo-bound form and a cargo-free form. In order to 
identify the residues that are critical in adopting and/or stabilizing these distinct CRM1 
conformations, we adopted an evolution-directed mutagenesis approach. CRM1 is an essential 
exportin in both lower eukaryotes (yeast) as well as mammals and is remarkably well conserved 
in the animal kingdom with human CRM1 sharing 98% identity with mouse (Mus musculus) and 
96% identity with fish (Danio rerio). The conservation of CRM1’s overall structure in the entire 
eukaryotic clade (from yeast to humans) indicates that the functional properties of the transport 
receptor have been essentially conserved across evolution. 
Here, we report that CRM1 sequence analyzed from 58 diverse eukaryotic clades  (Figure 5.1) 
starting from parasitic protozoans such as Trichomonas, Toxoplasma till higher eukaryotes 
including plants, fungi, amphibians and mammals revealed 20 absolutely identical residues that 
have not undergone any change throughout evolution. Such strong evolutionary conservation of 
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these residues in the CRM1 sequence from the bottom of the eukaryotic life to its top suggests 
that these residues must have been under strong evolutionary pressure and any substitutions in 
them has not been tolerated. Since, macromolecular conservation heavily correlates to its 
functional roles, we asked how changes in these residues would affect CRM1 function. To 
achieve this, subtle point mutations in these 20 residues in mmCRM1 were designed carefully to 
prevent any drastic changes in the overall CRM1 architecture.  
The effects for these mutations were readily visible in the binding assays, where binding of 
CRM1 point mutants to immobilized cargo (PKI-NES) and RanGTP was analyzed in comparison to 
the wild-type CRM1. In addition, the live export assays in HeLa nuclei analyzed the ability of 
these mutants to carry out multiple rounds of cargo-export through the NPCs in the context of 
in-vivo situation. 
4.1.5. Various conformational states of CRM1 mutants 
Mutations in the strictly conserved CRM1 residues resulted in generation of CRM1 mutants 
stabilized in different conformational states. Some of these mutations favored cargo-binding 
conformation while others stabilized cargo-free CRM1 conformation relative to the wild-type 
CRM1. 
G502A/S, P427G mutants bound both PKI-NES and RanGTP much stronger compared to the wild-
type CRM1. The binding to the cargo and RanGTP was high even when the other binding partner 
was absent. Thus, in these mutants a) CRM1 is stabilized in its ‘cargo-bound’ conformation and 
b) the binding cooperativity between RanGTP and cargo is essentially lost. These mutants did not 
carry out export of GFP-tagged cargo in the export assays as the cargo was predominantly 
localized in the nucleus even after prolonged incubation with mutant CRM1. In CRM1 export 
complex, both the residues G502 and P427 are located near the HC, with G502 being present 
towards the end of HEAT repeat 10B and P427 being part of the hinge region in the acidic loop 
formed by HEAT repeat 9. 
As described above, HEAT repeat 9 undergoes large structural changes in response to cargo and 
RanGTP. It appears form the structural studies that an extended acidic loop is probably required 
to maintain an open HC for cargo and RanGTP binding. In our experiments, exchanging a rigid 
proline located in the hinge region of this loop to a flexible glycine resulted in an enhanced cargo 
and RanGTP binding indicating an open HC state and probably an extended AL conformation. 
Thus, it appears that the rigidity imparted by P427 in the hinge region of AC is required to 
stabilize the ‘flipped back’ conformation of the AL.  
Comparing the structures of CRM1 in the export complex and unliganded CRM1 also shows 
rearrangement of side chains in the helices surrounding the HC. In our experiments, substituting 
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G502 in the HEAT repeat 10 with alanine (or serine) that differ from it in a single alkyl group, 
strongly stabilized CRM1 in a cargo-binding conformation. Since, an alanine or serine moiety is 
more rigid than glycine, it indicates that the flexibility in this region is of critical importance in 
stabilizing open and closed conformation of the hydrophobic cleft.  
It will be interesting to study both these mutants by structural analysis to observe how these 
conformations are indeed stabilized. Furthermore, since both these mutants bind cargo in a very 
stable manner, even in the absence of RanGTP, they are interesting candidates for crystallization 
of weak cargoes that have low affinity for CRM1 and hence as such cannot be crystallized. 
CRM1 mutations E513D, Q550N, Y551F, F554Y, M583L, F366M and Y788F resulted in a much 
stronger binding to the cargo than the wild-type CRM1. However, RanGTP cooperativity was 
maintained in this case. Both E513 and Q550 are located in the HEAT repeat 11 and are engaged 
in salt bridge interactions with R553 and K590 respectively, located in the adjacent HEAT 
repeats, to stabilize an open HC conformation in the export complex. A mutation in these 
residues, E513D and Q550N, led to an increased cargo and RanGTP binding thereby indicating 
that the cargo binding conformation is further stabilized. Substituted residues in both cases were 
highly similar in their nature to the original residues, yet such substitutions are not observed in 
nature. This suggests that in the cellular milieu, CRM1 sequence is highly optimized for binding 
to both high affinity and low affinity cargoes. The cargo used in our assays, PKI-NES, is an 
inherently weak cargo (Güttler et al., 2010). Although, we did not test these mutants for binding 
to strong cargoes such as supra-physiological NESs, it is clear that the affinities for weak cargoes 
can be enhanced drastically with these point mutations.  
Y551 is present in the linker region connecting helix 11B and 12A and hydrogen bonding with the 
residues in the adjacent HEAT repeats in the export complex. F554 on the other hand, is located 
at the far end of the HC between helices 11B and 12A whereas M583 is located at the base of 
HC. Mutation F554Y results in an additional hydroxyl group in the HC preventing its closure. 
M583 interacts directly with the cargo and participates in the formation of Φ pockets. The 
homologous residue in yeast M592 was recently also reported to adopt a different conformation 
in the unliganded scCRM1 compared to its conformation on CRM1 export complex (Saito and 
Matsuura, 2013). Thus, mutations in these conserved residues Y551F, F554Y and M583L might 
stabilize cargo-binding state of CRM1 by forcing an open HC conformation due to steric clashes 
with the neighboring residues. F66M and Y788F CRM1 mutants, on the other hand, harbor point 
substitutions in the conserved residues that are located far away from the HC. Still, these 
mutants resulted in much higher cargo and RanGTP binding compared to the wild-type CRM1. 
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This further confirms that the evolutionary conserved residues indeed are crucial in stabilizing 
one or the other CRM1 conformation. 
CRM1 mutations L80I, W91F, E176Q, F179M, L625A and D1017A resulted in extremely low 
affinities for PKI-NES and RanGTP binding. These mutants were predominantly stabilized in the 
cargo-free conformation. L80I (HEAT 2B), W91F (HEAT 2B), F179M (HEAT 4B), L625A (HEAT 13A) 
and D1017A (HEAT 21A) are present far away from the NES-binding site (HEAT 11 and 12) and 
hence do not participate in cargo-interaction or a direct RanGTP binding. E176 is however, 
involved in electrostatic interaction with RanGTP. Interestingly, all these mutants could bind a 
stronger NES (Super-PKI) (Figure 5.5). Super-PKI has very high affinity for CRM1 binding due to its 
rational design (Güttler et al., 2010) and is capable of forcing CRM1 into cargo-binding 
conformation even in the absence of RanGTP. Strong binding of these mutants to Super-PKI NES 
suggested that these mutants are indeed capable of binding cargoes, however, for weaker 
cargoes such as PKI-NES, the binding equilibrium is shifted towards the cargo-free state.  
4.1.6. Inherent structural flexibility forms the basis of NPC’s architectural and functional 
machinery 
In this project, we analyzed the structural features of the most versatile nuclear transport 
receptor CRM1 and the least understood NPC architectural element, the Nup62·58·54 
nucleoporin complex. Despite the diverse functional roles of CRM1 and Nup62·58·54 complex in 
forming the overall NPC functional and architectural machinery, inherent structural flexibility is a 
common theme and represents the dynamic nature of this machinery. While the structural 
flexibility in case of CRM1 is more pronounced and like in case of all other known NTRs, involves 
large-scale rigid body movements of its α-helical solenoidal fold in response to cargo binding and 
unbinding, the structural flexibility in case of Nup62·58·54 complex is more likely to be confined 
to the flexible hinge regions connecting the rigid α-helical, β-propeller or coiled-coil domains. 
This inherent structural flexibility poses serious challenges to its crystallization and structure 
determination. We overcame this problem for crystallization of Nup62·58·54 complex by 
selecting nanobodies that bind the flexible interfaces of Nup62·58·54 complex and in-turn 
rigidify it. CRM1 has already been crystallized in functional complexes with RanGTP and cargo, 
which also serve to rigidify its structure. For understanding the structural basis behind various 
conformational states of CRM1, we identified residues critical in imparting CRM1 its structural 
flexibility through mutating its evolutionary conserved residues.  
Our experiments reveal that nanobodies can act as powerful tools in crystallization of flexible 
molecules and most likely can also be used for crystallization of large NTR-cargo complexes, and 
other nucleoporin subcomplexes that have not been crystallized so far due to their structural 
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flexibility. They can also be used to stabilize weak interacting interfaces, such as those between 
nucleoporin subcomplexes, to gain information about nature of these interface regions. In our 
experiments, interface between Nup93 and Nup62·58·54 complex was surprisingly found to be 
very weak and might reflect a general nature of interaction between subcomplexes of vertebrate 
NPCs. Our approach of crystallizing subunits from different subcomplexes with the help of 
stabilizing nanobodies will result in a clearer picture of nucleoporin interaction and arrangement 
in the NPC and can be extended to other nucleoporin assemblies and NTR-cargo complexes. 
Moreover, we could also establish that single residues play a crucial role in stabilizing 
conformations of CRM1 and such evolutionary based mutagenesis approach can be applied to 
lock NTRs in one or other functional conformation, resulting in a rigid structure. 
As of now, we are far from understanding structural and functional properties of NPCs at an 
atomic scale resolution. Integrative approaches involving X-ray crystallography, NMR, Cryo-EM, 
single-particle techniques, super-resolution microscopy along with development of novel 
biochemical tools will help us understand the nature of this macromolecular machine. Studying 
differences in the nature of nucleoporin interaction in the NPCs from lower and higher 






5. Materials and Methods 
5.1. Materials 
Chemicals 
Chemicals of highest grade purity were purchased from the following suppliers-AppliChem 
GmbH (Darmstadt, Germany), Calbiochem (Part of Merck Millipore, Darmstadt, Germany), Carl 
Roth GmbH (Karlsruhe, Germany), GE Helathcare Europe GmbH (Frieburg, Germany) Life 
Technologies GmbH (Darmstadt, Germany), Merck Co. (Darmstadt, Germany), Pharmacia 
(Uppasala, Sweden), Roche Diagnostics (Mannheim, Germany), Serva Electrophoresis GmbH 
(Heidelberg, Germany), Sigma-Aldrich Co. (St. Louis, MO, USA) or Thermo Fisher Scientific 
(Walthom, MA, USA).  
 
Instruments  
Thermocycler    (SensoQuest, Göttingen, Germany)  
DNA Gel Imager    (Vilber Lourmat, Eberhardzell, Germany) 
MicroPulser electroporator  (Biorad, München, Germany)  
Nanodrop 2000c    (PEQLAB Biotechnologie GmbH, Erlangen, Germany) 
ISF1-X Climo-Shaker Incubator  (Kühner AG, Basel, Switzerland) 
Äkta purifier    (Pharmacia, Uppasala, Sweden) 
Sonifier     (Branson Ultrasonics, CT, USA) 
Biophotometer plus   (Eppendorf AG, Hamburg, Germany) 
Labfors3 bioreactor   (Infors, Bottmingen, Switzerland) 
Pipettman pipettes    (Gilson, WI, USA) 
5424 tabletop centrifuge   (Eppendorf AG, Hamburg, Germany) 
5424 R tabletop centrifuge   (Eppendorf AG, Hamburg, Germany) 
Haraeus multifuge 3SR   (DJB Labcare, Buckinghamshire, United Kingdom) 
Sorvall RC6 plus centrifuge   (Thermo Fisher Scientific, Walthom, MA, USA) 
Sorvall WX Ultra90 centrifuge  (Thermo Fisher Scientific, Walthom, MA, USA) 
Sorvall Discovery M120 centrifuge (Thermo Fisher Scientific, Walthom, MA, USA) 
MALS miniDAWN TREOS  (Wyatt Technology Europe GmbH, Dernbach, Germany) 
QELS Dynapro Nanostar  (Wyatt Technology Europe GmbH, Dernbach, Germany) 
TCS SP5 confocal microscope  (Leica Microsystems, Manheim, Germany) 
Cartesian 8-channel   (Genomic solutions/Digilab Inc, MA, USA) 
nanodispenser 
Freedom Evo liquid   (Tecan Group Ltd., Männedorf, Switzerland) 




Rock Imager automatic   (Formulatrix Inc, Walthom, MA, USA) 
Imaging system 
 
Buffers and standard solutions 
10x PfuS polymerase buffer  20mM Tris-HCl pH9.0, 250mM KCl, 15mM MgSO4,  
     100mM (NH4)2SO4, 1% Tween20, 1mg/ml BSA. 
10x DNA ligase buffer  500mM Tris pH7.5, 100mM MgCl2, 100mMDTT, 10mM  
     ATP, 250g/ml BSA. 
50x TAE (Tris-Acetate-EDTA) 242g  Tris-base, 57.1ml Acetic acid, 100ml 0.5M EDTA     buffer 
     pH8.0, ddH2O to 1l. 
2x SDS sample buffer  125mM Tris pH6.8, 3% SDS, 50mM DTT, 1M Sucrose,  
10x SDS-PAGE running buffer 300g Glycine, 60g Tris-base, 24g SDS, ddH2O to 2l. 
Orange-G DNA loading buffer 10mM Tris-HCl pH8.0, 10mM EDTA pH8.0, 50% Gly- 
     cerol (w/v), 0.25% Orange-G (w/v)  
Colloidal coomassie   0.08% (w/v) Coomassie brilliant blue G250, 1.6% (v/v)  
     ortho-phosphoric acid, 8% (w/v) Ammonium sulfate,  
     20% (v/v) Methanol.  
Coomassie stock solution  2% (w/v) Coomassie brilliant blue G250 in 50% ethanol 
20X E-Mix (energy-regenerating 20mM HEPES pH 7.5, 250mM Sucrose, 200mM 
 System)    Creatine phosphate, 10mM ATP, 10mM GTP,   
     1mg/ml Creatine kinase 
10X-Ran Mix   80µM RanGDP, 1µM RanBP1, 8µM RannGAP, 16µM (Ran-
regenerating system)  NTF2 
 
Software 
Lasergene 10   (DNA-Star, Madison, WI, USA) 
GeneDesigner 2   (DNA2.0, Menlo Park, CA, USA) 
Oligo 6.8    (Molecular Biology Insights, Cascade, CO, USA) 
Photoshop CS5   (Adobe Systems, San Jose, CA, USA) 
Papers 2    (Mekentosj, Aalsmeer, Netherlands) 
PyMol    (Schrödinger, Portland, OR, USA) 
Scaffold 3    (Proteome Software, Portland, OR, USA) 
Illustrator CS5   (Adobe Systems, San Jose, CA, USA) 
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Microsoft office 2011  (Microsoft Corporation, Redmond, WA, USA  
Bookends    (Sonny Software, Chevy Chase, MD, USA)   
LASAF    (Leica, Manheim, Germany) 
Mac OS X Vers.10.6.7  (Apple, Cupertino, CA, USA) 
UNICORN 5.0   (Amersham Biosciences, Uppasala, Sweden)  
Astra V    (Wyatt Technology, Santa Barbara, CA, USA) 
Virtual Box    (Oracle Corporation, Redwood Shores, CA, USA) 
Rockmaker    (Formulatrix Inc, Walthom, MA, USA) 
 
Online tools 
BLAST    http://blast.ncbi.nlm.nih.gov/Blast.cgi 
ClustalW    http://ebi.ac.uk/Tools/msa/clustalw2 
Uniprot    http://uniprot.org 
COILS    http://embnet.vital-it.ch/software/COILS_form.html 
Paircoils    http://gropus.csail.mit.edu/cb/paicoil/cgi-  
     bin/paircoil.cgi 
PSIPRED    http://bioinf.cs.ucl.ac.uk/psipred 
ProtParam    http://web.expasy.org/protparam 
Swiss Model   http://swissmodel.expasy.org/workspace 
Jalview    http://jalview.org 
Protein Data Bank   http://rcsb.org/pdb 
 
E.coli growth media 
LB liquid medium   1%  (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v)  
     NaCl 
2YT liquid medium   1.6%  (w/v) tryptone, 1% (w/v) yeast extract, 0.5%  
     (w/v) NaCl 
TB liquid medium   1.2%  (w/v) tryptone, 2.4% (w/v) yeast extract, 0.4%  
     (v/v) glycerol, 72mM K2HPO4, 17mM KH2PO4 
Culture plates   1.5% agar in LB or 2YT medium  
 
All media were autoclaved before use. Both LB and 2YT media were supplemented with 2% 
glycerol and 30mM K2HP04 for bacterial culture. Specific antibiotics at final concentrations of 
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ampicillin (100 µg/ml), kanamycin (25 µg/ml) and spectinomycin (50µg/ml) were added in the 




TOP 10F’ (Invitrogen)  F'(lacIqTn10(TetR)) mcrA Δ(mrr-hsdRMS-mcrBC)  
     φ80lacZΔM15  ΔlacX74 recA1 araD139 Δ(ara-leu)7697  
     galU galK rpsL endA1 nupG   
NEB turbo    F' proA+B+ lacIq ∆lacZM15 / fhuA2  ∆(lac- 
(New England Biolabs)  proAB) glnV galK16galE15R(zgb-210::Tn10)TetSendA1  
     thi-1 ∆(hsdS-mcrB) 
 
NEB 10-beta   Δ(ara-leu) 7697 araD139  fhuA ΔlacX74 galK16 galE15 (New 
England Biolabs)   e14-  φ80dlacZΔM15  recA1 relA1 endA1 nupG  rpsL  
     (StrR) rph spoT1 Δ(mrr-hsdRMS-mcrBC) 
 
Protein expression strains    
BLR (Invitrogen)   F-ompT hsdSB (rB
- mB
-) gal dcm Δ (srI-recA) 306::Tn10- 
     tetA 
NEB Express   fhuA2 [lon] ompT gal sulA11 R (mcr-73::miniTn10--(New 
England Biolabs)   TetS)2 [dcm] R(zgb-210::Tn10--TetS) endA1 Δ(mcrC- 
     mrr)114::IS10 
NEB Shuffle    F´ lac pro lacIq / Δ(ara-leu)7697 araD13 fhuA2 
(New England Biolabs)  Δ(lac)X74 Δ(phoA)PvuII phoR ahpC* galE (or U) galK  
     Δλatt::pNEB3-r1-cDsbC (SpecR, lacIq) ΔtrxB   
     rpsL150(StrR) Δgor Δ(malF)3 
Primers 
Highly pure oligonucleotides purified via desalting or HPLC, were synthesized from Sigma-
Aldrich. 
Plasmids 
All plasmids generated and/or used in this study were based on pQE-80 series (Qiagen) of 
vectors. ColE1ori (Qiagen )- 30-40 copies/cell; p15A  (kind gift from R.Lutz)- 10-12 copies/cell; 
CloDF3 ori- (Duet vector system, Novagen)- 30-40 copies/cell. 
 




Customized DNA sequences with optimized codon usage for protein expression in E.coli were 
obtained by de-novo synthesis from GenScript (Piscataway, NJ, USA). 
DNA Sequencing 
Plasmids were sequenced by DNA sequencing service from Seqlab (Göttingen). 
Crystallization screens 
96-tube format crystallization conditions screening suites – Classics, Classics II, Classics Lite, 
JSCG+, ProComplex, PEGs, PEGs II, PACT, ComPAS were obtained from Qiagen (Hilden, 
Germany); MIDAS was obtained from Molecular Dimensions (Suffolk, UK); Index was obtained 
from Hampton Research (Aliso Viejo, CA, USA) and Wizard 1+2, Wizard 3+4 were obtained from 
Emerald Biosystems (Bainbridge island, WA, USA). 
 
5.2. Methods 
5.2.1. Standard techniques in Molecular Biology 
Polymerase Chain Reaction (PCR) 
To amplify target DNA, oligonucleotide primers complementary to the region to be amplified, 
were synthesized with desired restriction enzyme recognition sites at their 5’ends. The DNA was 
amplified using polymerase chain reaction (Mullis et al., 1992) on the template DNA. High-
fidelity PfuS polymerase (produced in the lab by S.Frey) was used for all standard cloning 
reactions. 
A PCR mix was prepared as follows: 
50-100ng template DNA 
1X dNTP mix (from 10X stock dNTP mix containing 2.5mM each dATP, dCTP, dGTP, dTTP) 
1 µM forward primer (from 100 µM stock solution) 
1 µM reverse primer (from 100 µM stock solution) 
1X PfuS polymerase buffer (from 10X stock solution) 
1ng/µl PfuS polymerase (from 100ng/µl stock solution) 
ddH2O to adjust the final volume 
 
The protocol used for amplification included: 
Initial denaturation at 98°C for 2 min 
25-30X amplification cycles 
Denaturation at 98°C for 30 sec 
Primer annealing at Tannealing for 30 sec 
DNA elongation at 68°C for Tamp  
Final extension at 68°C for 7 min 
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Tannealing or annealing temperature implies average annealing temperature specific for primer pair 
based on primer length and composition. It was calculated using Oligo 6.8. 
Tamp or amplification time implies time duration for primer elongation on the given template. It 
depends on the amplification rate of the polymerase and length of template to be amplified. (For 
pfuS polymerase, amplification rate is ∼30sec/kb) 
Mutagenesis PCR 
For deletions of small parts from the target DNA, additions of few base pairs to the target DNA 
or for single amino acid substitutions, mutagenesis PCR was carried out. HPLC-purified, 5’-
phosphorylated primers were designed for amplifying the entire plasmid. PCR amplification was 
carried out as above. After amplification, the DNA was precipitated by addition of isopropanol 
(1:1 v/v) followed by centrifugation for 10 minutes (room temperature, 13,000 rpm). The 
supernatant was removed as completely as possible and the resulting pellet was suspended in 
Dpn1 digestion mix (25µl H2O, 3µl NEB buffer 4 and 2µl Dpn1 enzyme). The digestion was carried 
out at 37°C for 1h to digest the methylated non-mutated template DNA. The final product was 
purified by DNA gel electrophoresis and ligated (see below). 1-2µl of the ligation mix was 
transformed into electrocompetent E.coli cloning strains and plated on selection medium. The 
plates were incubated overnight at 37° C. 
Agarose gel electrophoresis 
Agarose gel electrophoresis separates DNA fragments based on their size. The protocol used was 
employed according to (Sambrook et al., 1989) 0.8-2% (w/v) agarose gel was prepared by 
dissolving agarose in TAE buffer followed by heating and cooling down. DNA samples mixed with 
1:10 (v/v) Orange-G DNA buffer were loaded on the gel and electric potential of ∼160V was 
applied. Electrophoresis was carried out for ∼30min and the DNA fragments were visualized 
under UV light. A small amount of DNA intercalating dye, Ethidium bromide (EtBr), was added to 
liquid agarose prior to gelation to promote visualization of DNA under UV light. 
DNA gel extraction and purification 
After agarose gel electrophoresis, size-separated DNA fragments were cut out from the gel. DNA 
was extracted from the agarose gel slices using Zymoclean Gel DNA recovery kit (Zymo Research, 
Freiburg, Germany) as per manufacturer’s instructions. 
DNA concentrations were determined with NanoDrop ND-2000 spectrophotometer. 
DNA digestion with restriction enzymes 
All restriction enzymes were purchased from NEB (New England Biolabs, Beverly, MA, USA). The 
enzymes were mixed with the DNA to be cleaved in the presence of buffers and reagents 
according to the manufacturer’s instructions. At least a two-fold excess of restriction enzyme 
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over DNA was used. The digestion reaction was performed at 37° C for 1h. For overnight 
digestion, the amount of enzyme used was reduced. After DNA cleavage, alkaline phosphatase 
treatment (FastAP, Fermentas) was carried out for 10min to remove phosphate groups from the 
ends of vector DNA to prevent religation during the subsequent ligation step.  The cleaved DNA 
was purified on agarose gels as above and size-specific bands were used for ligation. 
DNA Ligation 
A ligation reaction mix was prepared as follows: 
∼20ng/kb vector DNA (∼30fmol) 
∼40ng/kb insert DNA (∼60fmol) 
1X DNA ligation buffer (from 10X stock solution) 
1X E-mix (from 10X stock solution) 
10ng/µl T4 DNA ligase (produced in the lab by S.Frey) 
ddH2O to adjust the final volume to 10µl 
 
The ligation reaction was typically carried out at 37°C for 30min for sticky-ends and 16°C 
overnight for blunt-end DNA. 1µl of ligation mix was transformed in E.coli and plated onto 
selection media for further analysis. 
DNA transformation into E.coli by electroporation 
Electro-competent E.coli cells were prepared in the lab by G. Kopp. For electroporation, 1µl of 
ligation mix was mixed with 45µl of electro-competent E.coli cells in an electroporation cuvette 
(BioRad, Burlington, USA). Electroporation was performed with GenePulserTM (BioRad) according 
to manufacturer’s instructions. The electroporated cells were suspended in 1ml 2YT medium 
supplemented with 0.2% glucose and incubated at 37°C for 1h in a Thermomixer (Eppendorf, 
Germany) while shaking. Cells were subsequently plated on selective media containing 
appropriate antibiotics for plasmid selection and incubated overnight at 37°C. 
Colony PCR  
Colony PCR is and analytical method for identifying correct clones from bacterial colonies 
obtained on selection plates after ligation. In this method, bacterial cells are directly used as 
template for amplification rather than purified DNA. The technique relies on the fact that high 
temperatures used in the PCR reaction are sufficient to lyse the cells and expose the DNA for 
amplification. Therefore, a large number of clones can be screened simultaneously for 
identifying the gene of interest. For this, single bacterial colonies were picked up from plates 
with a toothpick or autoclaved pipette tips and thoroughly suspended in 50µl 2YT medium. 1µl 
of this mix was used in the PCR-mix (see above). Tth polymerase (produced in the lab by S.Frey) 
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was used for colony PCR. The products were analyzed on by DNA gel electrophoresis (as above) 
and positive hits were identified.  
Test protein expression 
Another method for fast screening of clones is small-scale test expression of protein encoded by 
the gene of interest. For this method, bacterial colonies were suspended in 250µl 2YT medium as 
above and grown for 2-3h at 37°C in Thermomixer, shaking at 1200rpm. 50µl of cell suspension 
of non- induced sample was set aside prior to addition of IPTG. To the rest of cell suspension, 
1mM Isopropyl-β-D-thiogalactopyranosid (IPTG) was added to induce expression of encoded 
protein and cells were grown further for 2h. Cells were spinned down in tabletop centrifuge and 
suspended in 100µl SDS sample buffer for analysis by SDS gel electrophoresis.  
Plasmid isolation from E.coli 
Small-scale plasmid purification was done using NuceloSpin® Plasmid Mini kit (Macherey Nagel, 
Germany) and a preparative-scale using NucleoBond® Xtra Midi kit (Macherey Nagel, Germany) 
according to the manufacturer’s instructions. 250ml bacterial cultures containing the target 
plasmid were grown at 37°C in LB medium supplemented with appropriate antibiotic. G.Kopp 
provided the technical assistance for plasmid isolation. 
DNA sequencing 
Plasmid DNA was sent to Seqlab Sequence Laboratories (Göttingen, Germany) for DNA 
sequencing. The results were analyzed with the SeqMan program of the Lasergene10 software. 
5.2.2. General protein expression and purification 
Protein Expression 
E.coli expression strains (Neb Express, BLR or NEB shuffle) were used for protein expression. 
Various parameters such as the nature of N-terminal affinity tags (expression enhancers, 
solubility enhancers), solubility of final product and yield of final product etc. determined the 
expression conditions like induction strength, expression time, and expression temperatures. 
Individual parameters were optimized individually for each protein, in an analytical-scale 
expression prior to large-scale expression. 
In general, ∼500ng plasmid DNA encoding the desired protein was transformed into electro-
competent E.coli cells. Cells were recovered by incubating in 1ml 2YT medium at 37°C for 1h 
while gently shaking. For co-transformation of two or more plasmids, plasmids were mixed 
together and a final DNA concentration of not more than ∼1000ng DNA was used for 
transformation. The transformed cells were plated on selective media containing appropriate 
antibiotics and incubated overnight at 37°C. A single colony was picked up and used for 
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inoculation of 100-150ml 2YT or TB medium containing appropriate antibiotics. The primary 
culture obtained after overnight bacterial growth at 30°C was used to inoculate secondary or 
expression cultures in the same medium (containing antibiotics) used for primary cultures. The 
cultures were grown at 30°C in 5L flasks till an OD600nm of 0.8-1.0 (for 2YT medium) or 2-3 (for TB 
medium) was obtained. Protein expression was induced by addition of Isopropyl-β-D-
thiogalactopyranosid (IPTG) at a final concentration of 0.025-1 mM (depending upon expression 
temperature and time). The cultures were grown further for 3-6h (at 28-37°) or 14-16h (at 18°C). 
The cells were harvested by centrifugation (at 5000rpm 10-15min, 4°C) in centrifugation buckets. 
Prior to harvesting, 1mM phenylmethanesulfonylfluoride (PMSF) was added to the culture as 
protease inhibitor whereas 10mM ethylenediaminetetraaceticacid (EDTA) was added to the 
centrifugation buckets. The culture supernatant was removed as completely as possible and the 
pellets were suspended in Resuspension buffer (50mM Tris-HCl pH7.5, 200-300 mM NaCl, 2-
10mM DTT) in a volume leading to an OD600nm of ∼200. Subsequently, the cells were either lysed 
directly or alternatively flash-frozen in liquid nitrogen and stored at -80°C till further processing.  
Cell lysis 
The cells were typically lysed by freeze/thawing followed by sonication (4X, 1min pulses with 
50% duty cycle) on ice. Clarified solutions were obtained from the crude lysates by 
ultracentrifugation (38,000 rpm for 2-3h) at 4°C. The supernatant was carefully removed and 
used further as starting material for affinity purification. 
Affinity chromatography with Ni+2 matrix 
Bivalent heavy metals such as Ni+2, Co+2 or Cu+2 etc. have high affinities for binding to Histidine 
residues commonly found in proteins. These metal ions form a reversible complex with 
imidazole rings of the His-residues at physiological pH, which can be dissolved by addition of 
excess of imidazole at high concentrations. This principle forms the basis of Ni+2 affinity 
chromatography used for purification of various poly-histidine tag containing recombinant 
proteins expressed in E.coli. The proteins were engineered to express a cleavable His10 or His14 
tag at their N-terminus (or non-cleavable His6 at C-terminus) for purification via Ni
+2 affinity 
chromatography.  
In general, 24% Ni+2 EDTA silica matrix (self-made by D.Görlich) was equilibrated with 
Resuspension buffer (as above) and mixed with clarified E.coli lysate containing recombinant 
protein. The mix was incubated at 4°C (cold room) for 1h while in constant rotation. 5-10mM 
imidazole was added to the binding mix to reduce non-specific binding of contaminant proteins. 
The mix was then applied to gravity-flow columns (Sigma-Aldrich) and the matrix was allowed to 
settle while the flow-through was collected. The affinity matrix was washed extensively (4-5 
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Column Volume or CV) with Wash buffer (50 Tris-HCl pH7.5, 100-200mM NaCl, 2-5mM DTT, 5-
10mM Imidazole). Bound protein was eluted off the matrix by addition of excess Imidazole 
(500mM Imidazole in wash buffer) in 500µl fraction volume. 1µl of each eluted fraction was 
blotted on nitro-cellulose membrane, which was stained with amido-black stain. The peak 
fractions containing highest amounts of protein were pooled together. Protein concentration 
was determined by measuring absorption at 260 and 280nm. Samples collected at each step of 
expression and purification were analyzed by SDS gel electrophoresis followed by Coomassie 
staining of protein bands. In some cases, buffer exchange was done using PD10 or Nap5 buffer 
exchange columns (GE Healthcare) to remove imidazole prior to freezing. Sucrose to a final 
concentration of 250mM was added to the purified proteins, which were flash-frozen in liquid 
nitrogen and stored at -80°C. 
Affinity chromatography with IgG-sepharose matrix 
ZZ-tag (derived form Protein A of S.aureus) is an expression (and solubility) enhancing affinity tag 
that binds strongly to the Fc region of IgG. Higher expression levels, greater solubility and 
reduced background levels of non-specific binders to IgG matrix are some advantages of using 
this tag. The ZZ affinity-tag was used in combination with His-tag to provide a complementary 
second round of purification in order to achieve higher purity or in analytical binding assays (see 
below) where low background binding of contaminant proteins was desired.  
In general, IgG sepharoseTM 6 Fast Flow (GE healthcare) was pre-washed 2-3X column volume 
with equilibration buffer (50 Tris-HCl pH7.5, 200-300mM NaCl) followed by washing with 0.2 M 
glycine buffer pH2.0 (3X column volume) and equilibrated again in the equilibration buffer (3X 
column volume). Recombinant protein containing N-terminal ZZ-tag was applied to the matrix 
and incubated for 2h at 4°C under rotating conditions. After binding, the matrix was washed 
thoroughly with equilibration buffer (3-4 CV) and the bound protein was eluted off the column 
by protease cleavage (see below). In case of small scale binding assays, SDS buffer was used for 
elution. 
In-solution protease cleavage of affinity tags and reverse Ni+2 chromatography 
For most recombinant proteins expressed in this study, recognition sites for endoproteases 
followed the N-terminal affinity tag. The endoproteases such as TEV protease, SUMO (Small-
ubiquitin-related modifier) protease and NEDD8 protease (S.Frey, manuscript in preparation) 
were expressed and purified in the lab (by S.Frey) and provided great tools for the design of 
orthogonal purification systems for engineered proteins. The recognition site for TEV protease is 
a small peptide motif (ENLYFQG) introduced at the C-terminus of the affinity tag, whereas SUMO 
and Nedd8 proteases recognize a tertiary-fold in the protein (SUMO or NEDD8) structure. 
5. Material and Methods   
 
 99 
Besides conferring protease cleavage sites, these proteases also served as expression and/or 
solubility enhancers.  
For in-solution protease cleavage, His-tagged protease was added to the Nickel-eluate (imidazole 
exchanged using PD10 desalting column) in appropriate amount (100-fold excess of substrate 
over protease for TEV and NEDD8 protease, 1000-fold excess of substrate over protease for 
SUMO protease). The mix was incubated for 30min-1h for SUMO and NEDD8 proteases and 
overnight for TEV protease cleavage at 4°C.  
The protease along with the cleaved-off His-tags, un-cleaved target protein and other non-
specific contaminants were removed by rebinding of the mix to the Nickel matrix (described 
above). The flow-through was collected and used as purified protein for further analysis.  
On-column protease elution 
In order to achieve a higher level of purity, bound proteins can be eluted directly from the 
affinity matrix by protease cleavage. The method has advantage over other methods of protein 
elution (eg. Imidazole or SDS elution) that the non-specifically bound proteins are not eluted off 
the column. In addition, protein can be eluted directly in the storage buffer and therefore, it 
bypasses the need for another round of buffer exchange and removal of affinity tag by reverse 
Ni+2 chromatography (as described above). Therefore, the method combines high specificity with 
time-efficiency to achieve large amounts of pure protein. 
For on-column protease elution, proteins were bound to the Ni+2 matrix as before. The column 
was plugged from the bottom and 1-2ml of Wash buffer (50Tris pH7.5, 100-200mM NaCl, 2mM 
DTT, 5-10mM Imidazole ± 250mM sucrose) was added. Untagged protease in appropriate 
amount (100-1000 fold less protease than estimated substrate amount) was added to the matrix 
and mixed. The digestion was allowed to proceed at 4°C for 30min-1h after which the flow 
through was collected. The matrix was washed with 2-3X bed-volume of Wash buffer and 500µl 
sized fractions were collected. The eluted fractions were analyzed by amido-black staining and 
peak fractions were pooled together.  
Gel filtration chromatography 
Gel filtration (a.k.a. size-exclusion chromatography) purifies proteins by separating them 
according to differences in their molecular size and shape. Thus, protein aggregates and 
degradation products can be efficiently removed from the target protein. The matrix used in gel-
filtration chromatography comprises of porous beads, which based on their cut-off size, allow 
small molecules to enter, whereas large molecules are excluded and therefore, elute first from 
the column. SuperdexTM 75 (separates proteins in the range of 3-70kDa) and SuperdexTM 200 
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(separates proteins in the range of 10-600kDa) columns (Amersham) were used for gel filtration 
chromatography on Äkta Purifier/Explorer system (GE Healthcare).  
The columns were equilibrated with 1.5-2 CV of appropriate buffer (typically 20mM Tris-HCl pH 
7.5, 100-200mM NaCl, 1-2mM DTT) prior to sample injection. The protein was concentrated (see 
protein concentration) to a final volume of 1-5ml (for HiLoad 16/60 columns) and aggregates 
were removed by ultracentrifugation at 30,000 rpm for 30min at 4°C. The sample was applied via 
the sample loop with the help of a syringe into the system. The gel filtration was carried out 
according to manufacturer’s instructions and samples were collected after the void volume and 
peak fractions were analyzed by SDS-PAGE electrophoresis. 
Anion-exchange chromatography 
Ion-exchange chromatography resolves proteins according to differences in their surface charge. 
The method relies on the fact that surface charge of protein molecules is dependent upon the 
ionization state of amino acid residues, which in turn depend upon the pH of the buffer. Proteins 
tend to have a net negative surface charge at pH above their isoelectric point (pI) and a net 
positive charge at the pH below it. Therefore, a protein molecule at a pH above its pI binds 
positively charged matrix such as Q-sepharose. Different anion-exchange columns such as HiTrap 
Q FF, Mono Q HR 5/5 GL, Mini-Q 4.6/50 PE (GE healthcare) and Souce-15 Q (self-made by 
J.Schuenemann) were tested for binding and maximum resolution. 
In general, the column was equilibrated with 5-10 CV of low-salt binding buffer or Buffer A 
(20mM Tris pH 7.5, 50mM NaCl, 1mM DTT) followed by high-salt elution buffer or Buffer B 
(20mM Tris pH 7.5, 2M NaCl, 1mM DTT) and again brought back to Buffer A. Before loading onto 
the column, the salt concentration in the protein-solution was adjusted to 50mM NaCl either by 
dilution or buffer-exchange using PD10 column. Protein was slowly applied to the column at the 
concentration of 0.5-1 mg/ml and a flow rate of 0.5-1ml/min. After binding, the column was 
washed thoroughly with 10-15 CV of Buffer A at the default flow-rate. Elution was done by 
gradual increase in the ionic strength by applying a gradient of 0-30 % Buffer B over 10 CV. 500µl 
fractions were collected during the gradient application. Peak fractions were analyzed by SDS-
PAGE electrophoresis and pooled together for further analysis. 
Laemmli SDS-PAGE electrophoresis 
Denaturing sodiumdodecylsulfate-polyacrylamide (SDS-PAGE) electrophoresis separates protein 
according to their molecular weights and is a standard method for visual analysis of protein 
samples (Laemmli, 1970). SDS binds proteins and confers them with equal charge:mass ratio 
causing them to migrate under the influence of an electric field towards the positive electrode 
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based upon their molecular weight. The proteins can then be visualized by staining the gel with 
Coomassie stain. 
The composition of 7.5-16% gradient gels prepared in the lab by G.Kopp is as follows: 





Separating gel (16%) 
(200ml)* 
2M Tris pH8.8 - 40ml 40ml 
0.5M Tris PH6.8 15ml - - 
ddH2O 68ml 107ml 32ml 
2M Sucrose - - 10ml 
Glycerol (87%) - - 8ml 
SDS (10%) 1ml 2ml 2ml 
Rotiphorese Gel 30 15ml 51ml 108ml 
TEMED 100µl 120µl 120µl 
APS (10%) 1ml 2x 580µl 2x 580µl 
TEMED= Tetramethylethylenediamine 
APS= Ammonium persulfate 
* (Recipe for 10 gels) 
 
Prior to application on the gel, protein samples were mixed with equal volumes of 2X SDS 
sample buffer and boiled at 95°C for 5-8 min while shaking. The samples were centrifuged 
shortly and 5-15µl was applied to the gel. Electrophoresis was carried out at a constant current 
of 50mA till the loading front reached the bottom of the gel. Proteins were fixed by heating in 
3% acetic acid and stained with stained with approx. 1:1000 dilution of Coomassie stock solution. 
Gels were destained in ddH2O and scanned using Perfection V700 photo scanner (Epson, Tokyo, 
Japan). 
5.2.3. Specific purification protocols 
5.2.3.1. xlNup62·58·54 complex 
Nup62·58·54 complex was purified by co-expression of His14 brSUMO_Nup54 (pHC140) with 
ZZbrSUMO_Nup62_rbs_ZZbrSUMO_Nup58 (pHC140) in E.coli NEB Express (New England Biolabs) 
expression strain. Transformed cells were grown overnight in TB medium at 28°C in the presence 
of 25µg/ml Kanamycin and 50µg/ml Spectinomycin. Expression culture was grown by inoculating 
30ml of the primary culture into fresh TB medium supplemented with antibiotics. Protein 
expression was induced at an OD600nm of 2.5-3.0 by addition of 200µM IPTG. Cells were grown 
overnight at 18°C and processed as described before.  
 





Steps followed for the purification of Nup62·58·54 complex: 
1. IMAC (50mM Tris-HCl pH7.5, 200mM NaCl, 5mM DTT) 
2. On-column protease elution (50mM Tris-HCl pH7.5, 200mM NaCl, 5mM DTT, 10mM 
Imidazole) 
3. Gel filtration chromatography (20mM Tris-HCl pH7.5, 100mM NaCl, 2mM DTT) in SuperdexTM 
200 gel filtration column (GE Healthcare). 
4. Anion exchange chromatography (Buffer A- 20mM Tris-HCl pH7.5, 50mM NaCl, 2mM DTT; 
Buffer B- 20mM Tris-HCl pH7.5, 2M NaCl, 2mM DTT). The complex eluted at 250-300 mM NaCl 
during gradient elution from MonoQ HR 10/10 anion-exchange column (GE healthcare). 
5.2.3.2. xlNup62·58·54·93N complex 
Nup62·58·54·93N complex was purified by coexpression of His14 brSUMO_Nup93N (pHC150) 
with ZZbrSUMO_Nup62_rbs_ZZbrSUMO_Nup58_ZZbrSUMO_Nup54 (pHC149) in E.coli NEB 
Express (New England Biolabs) expression strain. Transformed cells were grown overnight in TB 
medium at 28°C in the presence of 25µg/ml Kanamycin and 50µg/ml Spectinomycin. Expression 
culture was grown by inoculating 30ml of the primary culture into fresh TB medium 
supplemented with antibiotics. Protein expression was induced at an OD600nm of 2.5-3.0 by 
addition of 200µM IPTG. Cells were grown overnight at 18°C and processed as described before.  
 




Steps followed for the purification of Nup62·58·54·93N complex: 
1. IMAC (50mM Tris-HCl pH7.5, 300mM NaCl, 5mM DTT) 
2. On-column protease elution (50mM Tris-HCl pH7.5, 300mM NaCl, 5mM DTT, 10mM 
Imidazole) 
3. Gel filtration chromatography (50mM Tris-HCl pH7.5, 200mM NaCl, 2mM DTT) in SuperdexTM 
200 gel filtration column (GE Healthcare). 
5.2.3.3. Nanobody expression and purification 
For periplasmic expression, nanobody sequences were cloned in pHEN6c vectors containing N-
terminal secretion signal sequence fused in-frame to Nb sequence. Cytoplasmic expression of 
nanobodies was carried out in E.coli NEB SHuffle strains (New England Biolabs). His14-NEDD8-Nb 
constructs were transformed and grown overnight at 30°C in 2YT medium supplemented with 
40% glycerol and 30mM K2HPO4. For nanobody expression, the culture was diluted with fresh 
medium to OD600nm 0.8-1.0 and induced with 300µM IPTG and grown further for 5h. The cells 
were harvested and processed as before. The nanobodies were purified by IMAC in a buffer 
lacking DTT (50mM Tris-HCl pH 7.5, 300mM NaCl) and eluted with imidazole. The eluent was 
applied to SuperdexTM 75 column equilibrated in 50mM Tris-HCl, 200mM NaCl and the peak 
fractions were collected.  
5.3. Nanobody conjugation to xlNup62·58·54 complex 
For complex formation between Nup62·58·54 complex and Nb15, purified Nup62·58·54 complex 
(10-20 mg) and His14-NEDD8-Nb15 were mixed together in 1:1 molar ratio and incubated at 
25°C for 30min. The complex was then bound to 2-3 ml Ni+2-EDTA affinity matrix (pre 
equilibrated with 50 Tris-HCl pH7.5, 200mM NaCl, 1mM DTT) and eluted via on-column cleavage 
by NEDD8 protease (1:100 protease: substrate ratio). The complex was applied to HiLoad 
SuperdexTM 200 16/60 gel filtration column equilibrated in 20mM Tris-HCl pH 7.5, 100mM NaCl, 
1mM DTT). The peak fractions from gel filtration column were analyzed by SDS PAGE, pooled 
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together, and concentrated by ultrafiltration using Vivaspin 6 centrifugal concentrators 
(Sartorius, Göttingen) according to manufacturer’s instructions. The concentrated samples (8-10 
mg/ml) were frozen in 100µl aliquots and used for crystallization.  
5.4. Limited proteolysis of xlNup62·58·54 complex 
For probing the structure of core Nup62·58·54 complex, limited proteolysis with chymotrypsin 
was performed. For analytical scale digestion, 1mg/ml Nup62·58·54 complex was incubated with 
chymotrypsin (Roche) in 1:1000(w/w) protease: substrate ratio at 4°C. Samples were taken out 
before protease addition and at indicated time intervals after protease addition, mixed with 
equal volumes of SDS sample buffer and boiled immediately at 95°C for 10min. The samples 
were analyzed on SDS-PAGE to identify stable fragments.  
For large scale limited proteolysis, 1ml of 10mg/ml Nup62·58·54 complex was incubated with 
chymotrypsin (1:1000 w/w) for 2h at 4°C. The digested sample was immediately loaded on 
HiLoad SuperdexTM 200 16/60 (Pharmacia, Uppasala, Sweden) column pre equilibrated with gel 
filtration buffer (20mM Tris-HCl pH 7.5, 100mM NaCl, 2mM DTT). Gel filtration was performed as 
above and eluted fractions were analyzed by SDS-PAGE. The gel was stained with colloidal 
coomassie and indicated bands were analyzed by Mass spectrometry.  
5.5. Molecular weight determination by Static light scattering (SLS)  
Multi-angle Light scattering (MALS) is an analytical technique to determine the absolute 
molecular mass, size and conformation of protein molecules based upon scattering of light by 
them in solution. In MALS system, a beam of polarized light is focused onto the sample molecule 
and the scattered light is detected with photo detectors at various angles to the incident light. To 
determine the molecular weight (MW) and root mean square radius (rms) of the protein, static 
light scattering coupled with SEC (size exclusion chromatography) was used. 200µl of purified 
protein sample (1mg/ml) was loaded to SuperdexTM 200 10/300 GL (GE healthcare) column and 
gel filtration chromatography was performed as described above. As the protein eluted from the 
column, several online detectors coupled to the column analyzed it. The first detector in series is 
the refractive index (RI) detector (Shodex RI-101, Showa Denko KK, Japan) With this detector, 
the refractive index and the UV-absorbance at 280nm of the protein sample was measured and 
the concentration of the protein was calculated. The scattered light was then recorded at three 
different angles by in-built detectors in the miniDAWNTM TREOS detector (Wyatt technology 
Europe). From the intensity of scattered light at different angles and the protein concentration, 
the absolute molecular weight and rms radius was determined using Astra® 6 software (Wyatt 
Technology). 
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5.6. Polydispersity analysis using Dynamic Light scattering (DLS)  
DLS measures the intensity of scattered light by molecules in solution as a function of time. 
Random Brownian motion of macromolecules leads to time-dependent fluctuations in the 
intensity of the scattered light. In DLS, a fast photon counter measures these fluctuations. The 
fluctuations can be quantified and directly relate to the hydrodynamic radius of the 
macromolecule. In general, large molecules diffuse slower than the small molecules. Thus, DLS 
can be used to determine the quality of a protein solution. A solution containing different 
particle populations such as protein aggregates, higher order oligomers and monomeric protein 
is considered polydisperse and not suitable for crystallization whereas a sample with a single 
homogeneous population of target protein is monodisperse and a requirement for 
crystallization.  
20µl of protein sample was pipetted in disposable plastic microCuvettes (Wyatt technology) and 
inserted into the sample holder of DynaPro NanoStarTM  (Wyatt Technology) for batch-mode 
measurement. Measurements were performed according to the manufacturer’s instructions and 
data analysis was done using Astra® 6 software (Wyatt Technology).   
5.7. Mass spectrometry 
Mass-spectrometric analysis was used for the identification of the protease-resistant regions of 
Nup62·58·54 complex subjected to limited proteolysis and for the identification of neighboring 
cysteine residues in the Nup62·58·54 complex after crosslinking. In each case, SDS PAGE analysis 
of the sample followed by colloidal Coomassie staining was used as a starting material for MS 
analysis (done in the lab of Prof H.Urlaub).  
5.8. Protein crystallization 
Samples of highest possible purity at high concentrations were used for obtaining protein 
crystals for X-ray crystallography. Vapor-diffusion method was used as a method of choice as it is 
the most commonly used method and can be used in combination with automated set ups for 
screening large amounts of crystallization conditions. In this method, a small volume of the 
concentrated protein sample is mixed with the same volume of crystallization solution (e.g. 
buffer, salt or precipitant; generally a combination of all three) and placed in a sealed reservoir 
containing the crystallization solution. In vapor diffusion with hanging-drop method, the sample 
is placed on a cover slip that is used to seal the reservoir, whereas in the sitting-drop method, 
the sample is placed inside a well surrounded by the reservoir solution. The difference in the 
concentration of components between the sample and reservoir solution causes vapor diffusion 
of the solvent until equilibrium is reached. During equilibrium, super saturation of the protein is 
achieved in the drop, which may lead to crystallization. All crystallography experiments were 
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performed in the central crystallization facility of MPI for biophysical chemistry headed by Dr. 
V.Pena. 
5.8.1. Sparse matrix screening with 96-well MRC sitting drop plates 
For obtaining initial crystallization hits, large numbers of commercially available crystallization 
screens were tested (See Materials section). Crystallization drops were set up in 96 well sitting 
drop MRC plates (Hampton Research) using Cartesian Microsys (Genomic Solutions /Digilab) 
Nano dispenser robot. 60nl of reservoir solution (containing the precipitant) was pipetted 
followed by 60nl of protein (8-16 mg/ml) into the round wells of MRC plates. Two different 
protein concentrations were used for the initial screens. After pipetting, the plates were sealed 
tightly with a clear sealing tape and stored at 20°C or 4°C  (both temperatures were screened for 
each condition) in automated robotic imager (Formulatrix). Crystal growth was monitored over 
time using RockImager software (Formulatrix), which was used to take images of the 
crystallization drops at regular intervals.  
5.8.2. Grid screening with 96-well MRC sitting drop plates 
Initial crystallization hits obtained from sparse matrix screens were further optimized for 
increased crystal quality and size by screening around the initial crystallization conditions (grid 
screening). Grid screens were designed using RockMaker software (Formulatrix) by varying the 
concentration and pH of components in the initial hit condition around their original 
concentration and pH.  The plates were pipetted as above and monitored on regular intervals. 
5.8.3. 24-well Linbro hanging drop plates 
For further refinement of crystal quality and to obtain larger crystals, manual drops were set up 
with hanging drop method using 24-well Linbro plates. Successful crystallization conditions from 
the grid screen were pipetted in the wells of 24-well plates. 1-2µl of reservoir solution was mixed 
with 1-2µl of protein solution on a cover slip. Generally, the volume ratio between reservoir and 
protein drop was also varied between 1:1, 1:1.5 or 1:2 and 3-4 drops were set per coverslip. 
After the drops were placed, the coverslip was inverted and placed on the well containing 1ml 
reservoir solution. The upper boundary of the wells was pre greased with silicone grease (Jena 
Bioscience) for sealing the crystallization chamber. The plates were left undisturbed at 20°C or 
4°C and monitored at regular time intervals by visual examination under Leica MZ6 microscope 
(Leica Microsystems).  
5.8.4. Additive screen set up 
Additives such as traces of metal ions, organic polymers, and alcohols etc. are known to improve 
crystal quality by manipulating protein-protein or protein-solvent interactions. Commercially 
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available 96 tube format additives screens (Hampton research) were used to set up 
crystallization plates with optimized precipitant conditions. 16µl of additive was mixed with 64µl 
of precipitant in the reservoir. 120nl of reservoir containing the additive and 120nl of protein 
were added to the wells of 96-well MRC plate using the Nano dispenser robot as described 
above. The plates were sealed and imaged at regular intervals with the automated robotic 
imager (Formulatrix). 
5.8.5. Flash cooling in liquid nitrogen and data collection 
Protein crystals were carefully fished out of the mother liquor using Nylon loops mounted on a 
magnetic head (mounted CryoLoops, Hampton Research) of 0.02-0.5µM in size. Prior to freezing, 
crystals were first pre equilibrated in a suitable cryo-protectant (glycerol, ethylene glycol, xylitol, 
sucrose, PEG 400) for preventing ice-crystal formation inside or surrounding the protein crystal 
during freezing.  Typically, a series of drops containing increasing concentration of cryo-
protectant in the reservoir solution were pipetted. The crystal was transferred from one drop to 
another with a 30sec-3min incubation-period per drop. The crystal was finally fished out of the 
drop and plunged in liquid nitrogen for freezing. Diffraction data from cryo-cooled crystals were 
collected at 100 K on a Pilatus detector at the Swiss Light Source (Switzerland) beamline PXII.  
5.8.6. In-situ proteolysis 
In situ-proteolysis was performed as described in (Dong et al., 2007). α-chymotrypsin 
(SIgmaC3142) dissolved at a concentration of 1mg/ml in a solution containing 1mM HCl and 
2mM CaCl2, was added to purified protein on ice immediately prior to crystallization trials at a 
ratio of 0.01-1µg of chymotrypsin per mg of protein, dissolved at 10-15 mg/ml in 20mM Tris 
pH7.5 and 100mM NaCl. Crystallization trays were set up immediately as described in section 
6.10.1. 
5.9. Binding assays for CRM1 mutants  
20µl IgG-sepharose 6 FastFlow (Amersham Biosciences) was washed twice with 10CV of binding 
buffer (50mM Tris-HCl pH7.5, 300mM NaCl), 2X with 10CV of 200mM Glycine-HCl pH2.0 followed 
by equilibration in binding buffer. ZZ-tagged baits (PKI-NES or RanGTP Q69L 1-180) were mixed to 
saturate the beads and excess bait was washed away by 2X wash in the binding buffer. Binding 
mix was prepared by adding CRM1 to PKI-NES or RanGTP (1µM final concentration of each 
component in 500µl binding buffer) in the presence of 1X E-mix. Bait-saturated IgG beads were 
incubated in the binding mix for 2-3hrs after which beads were washed 3X with the binding 
buffer. Bound material was eluted from the column by addition of 50µl SDS sample buffer. 
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5.10. Live export assays in HeLa nuclei 
HeLa nuclei were prepared as described in (Stuven et al., 2003). High-speed X.laevis egg-extract 
was depleted for nuclear transport receptors by passing it through phenyl-sepharose column 
(low-substitution, Pharmacia) using 500µl beads per 1ml of the extract. For export experiments, 
1µl HeLa nuclei were incubated with 7µl of depleted egg-extract in the presence of 1XRan-mix 
(Ran-regenerating system) and 4µM fluorescently-labeled cargo for 30 minutes at 23°C. 1µM 
wild-type CRM1 or CRM1 mutant was added to the mix and incubated for further 10 minutes. 
Just before imaging, 1µM mCherry and 2µg/ml DAPI were added to the nuclei. 1µl of the mix 
was placed on the wells of a 10-well multi-test slide and covered with a cover slip. Imaging was 
performed with a confocal laser-scanning microscope system (SP5, Leica) using 63X- numerical 
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Cryo-ET     cryo-electron tomography 
ct      Chaetomium thermophillum 
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